Psyllid ID: psy14371

Local Sequence Feature Prediction

Prediction and (Method)Result
Residue Number Marker
Protein Sequence ?
Secondary Structure (PSIPRED) ?
Secondary Structure Prediction (SSPRO) ?
Coil and Loop (DISEMBL) ?
Flexible Loop (DISEMBL) ?
Low Complexity Region (SEG) ?
Disordered region (IsUnstruct) ?
Disordered Region (DISOPRED) ?
Disordered Region (DISEMBL) ?
Disordered Region (DISPRO) ?
Transmembrane Helix (TMHMM) ?
Transmembrane Helix (HMMTOP) ?
Transmembrane Helix (MEMSAT) ?
TM Helix, Signal Peptide (MEMSAT_SVM) ?
TM Helix, Signal Peptide (Phobius) ?
Signal Peptide (SignalP HMM Mode) ?
Signal Peptide (SignalP NN Mode) ?
Coiled Coils (COILS) ?
Positional Conservation ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280------
MNYDVIAYGSVYRDVKLHDLPSLRVPSAAKLNLHDFKFDDIHMEDDDTLKVAELVSSEFFEQGDIERQELNITPIDIMNREKEDQLPLMQVGFIDSICLPIYESTQWWKIFGEIECLALLIACLCHDLDHRGTNNSFQINNVSPDEYSRIIKVLEEAILSTDLAVYFRQRGSFLSLVKGGSLAWHREADRDLAVYFRQRGSFLSLVKGGSLAWHREADRGLLRGMTMTVCDLAAITKPWHVEKRAFAELSDKLEPLVEGVRSNKQHWLEIAAEKRKQDERERCAES
cHHHHHHHcccccHHHHHHccccccccccccccccccccccccccccHHHHHHHHHHHHHHcccccccHHHHHHHHHHHccccccccccccHHHHHHHHHHHHHccccccccHHHHHHHHHHHHHHcccccccccccccccccHHHHHccccHHHHHHHHHHHHHHHccccHHHHcccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHcHHHHHccccccccHHHHHHHHHHHHHHHHcHHHHHHcccccccHHHHHHcccHHHHHHcc
cHHHHHHHHccccHHHHHHHHHccccccHHccccEEEccccccccHHHHHHEEEEHHHHHHHccccHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHHcccHHHHHHHHHHHHHHHHHHHcccccccccccHHHccccHHHHHHccHHHHHHHHHHHHHHHHcccccHHHcccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccHHHHHHHHHHHHHHHHHHHccccHHHHHHHHHHHHHHccccccccHHHHHccccccccHcHHHHccccccc
MNYDVIAygsvyrdvklhdlpslrvpsaaklnlhdfkfddihmedddTLKVAELVSseffeqgdierqelnitpidimnrekedqlplmqvgfidsiclpiyestqWWKIFGEIECLALLIACLChdldhrgtnnsfqinnvspdEYSRIIKVLEEAILSTDLAVYFRQRGSFlslvkggslawhreADRDLAVYFRQRGSFlslvkggslawhreaDRGLLRGMTMTVCDLAAITKPWHVEKRAFAElsdkleplvegVRSNKQHWLEIAAEKRKQDERERCAES
mnydviaygsvyrdvklhdlpslRVPSAAKLNLHDFKFDDIHMEDDDTLKVAELVSSeffeqgdierqelnitpidIMNREKEDQLPLMQVGFIDSICLPIYESTQWWKIFGEIECLALLIACLCHDLDHRGTNNsfqinnvspDEYSRIIKVLEEAILSTDLAVYFRQRGSFLSLVKGGSLAWHREADRDLAVYFRQRGSflslvkggslawHREADRGLLRGMTMTVCDLAAITKPWHVEKRAFAelsdkleplvegvrsnkqhwLEIAaekrkqderercaes
MNYDVIAYGSVYRDVKLHDLPSLRVPSAAKLNLHDFKFDDIHMEDDDTLKVAELVSSEFFEQGDIERQELNITPIDIMNREKEDQLPLMQVGFIDSICLPIYESTQWWKIFGeieclalliaclchdldhRGTNNSFQINNVSPDEYSRIIKVLEEAILSTDLAVYFRQRGSFLSLVKGGSLAWHREADRDLAVYFRQRGSFLSLVKGGSLAWHREADRGLLRGMTMTVCDLAAITKPWHVEKRAFAELSDKLEPLVEGVRSNKQHWLEIAAEKRKQDERERCAES
**YDVIAYGSVYRDVKLHDLPSLRVPSAAKLNLHDFKFDDIHMEDDDTLKVAELVSSEFFEQGDIERQELNITPIDIMNREKEDQLPLMQVGFIDSICLPIYESTQWWKIFGEIECLALLIACLCHDLDHRGTNNSFQINNVSPDEYSRIIKVLEEAILSTDLAVYFRQRGSFLSLVKGGSLAWHREADRDLAVYFRQRGSFLSLVKGGSLAWHREADRGLLRGMTMTVCDLAAITKPWHVEKRAFAELSDKLEPLVEGVR***QHWLE*****************
MNYDVIAYGSVYRDVKLHDLPSLRVPSAAKLNLHDFKFDDIHMEDDDTLKVAELVSSEFFEQGDIERQELNITPIDIMNREKEDQLPLMQVGFIDSICLPIYESTQWWKIFGEIECLALLIACLCHDLDHRGTNNSFQINNVSPDEYSRIIKVLEEAILSTDLAVYFRQRGSFLSLVKGGSLAWHREADRDLAVYFRQRGSFLSLVKGGSLAWHREADRGLLRGMTMTVCDLAAITKPWHVEKRAFAELSDKLEPLVEGV**************************
MNYDVIAYGSVYRDVKLHDLPSLRVPSAAKLNLHDFKFDDIHMEDDDTLKVAELVSSEFFEQGDIERQELNITPIDIMNREKEDQLPLMQVGFIDSICLPIYESTQWWKIFGEIECLALLIACLCHDLDHRGTNNSFQINNVSPDEYSRIIKVLEEAILSTDLAVYFRQRGSFLSLVKGGSLAWHREADRDLAVYFRQRGSFLSLVKGGSLAWHREADRGLLRGMTMTVCDLAAITKPWHVEKRAFAELSDKLEPLVEGVRSNKQHWLEIAA**************
MNYDVIAYGSVYRDVKLHDLPSLRVPSAAKLNLHDFKFDDIHMEDDDTLKVAELVSSEFFEQGDIERQELNITPIDIMNREKEDQLPLMQVGFIDSICLPIYESTQWWKIFGEIECLALLIACLCHDLDHRGTNNSFQINNVSPDEYSRIIKVLEEAILSTDLAVYFRQRGSFLSLVKGGSLAWHREADRDLAVYFRQRGSFLSLVKGGSLAWHREADRGLLRGMTMTVCDLAAITKPWHVEKRAFAELSDKLEPLVEGVRSNKQHWLEIA***************
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHoooHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MNYDVIAYGSVYRDVKLHDLPSLRVPSAAKLNLHDFKFDDIHMEDDDTLKVAELVSSEFFEQGDIERQELNITPIDIMNREKEDQLPLMQVGFIDSICLPIYESTQWWKIFGEIECLALLIACLCHDLDHRGTNNSFQINNVSPDEYSRIIKVLEEAILSTDLAVYFRQRGSFLSLVKGGSLAWHREADRDLAVYFRQRGSFLSLVKGGSLAWHREADRGLLRGMTMTVCDLAAITKPWHVEKRAFAELSDKLEPLVEGVRSNKQHWLEIAAEKRKQDERERCAES
no confident homologs detected

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST ?

Original result of BLAST against SWISS-PROT Database

ID ?Alignment graph ?Length ? Definition ? RBH(Q2H) ? RBH(H2Q) ? Q cover ? H cover ? Identity ? E-value ?
Query286 2.2.26 [Sep-21-2011]
Q9VJ79 1451 Dual 3',5'-cyclic-AMP and yes N/A 0.835 0.164 0.376 3e-52
B4JXX2 1078 cGMP-specific 3',5'-cycli N/A N/A 0.751 0.199 0.278 9e-25
B4NAL6 1127 cGMP-specific 3',5'-cycli N/A N/A 0.751 0.190 0.278 2e-24
B4K9L4 1116 cGMP-specific 3',5'-cycli N/A N/A 0.751 0.192 0.275 3e-24
B4LVU6 893 cGMP-specific 3',5'-cycli N/A N/A 0.678 0.217 0.289 4e-24
B4PSS5 1149 cGMP-specific 3',5'-cycli N/A N/A 0.751 0.187 0.272 5e-24
Q298P4 1110 cGMP-specific 3',5'-cycli no N/A 0.751 0.193 0.265 5e-24
Q9VFI9 1118 cGMP-specific 3',5'-cycli no N/A 0.751 0.192 0.272 5e-24
B3P3K2 1131 cGMP-specific 3',5'-cycli N/A N/A 0.751 0.190 0.272 7e-24
B4QZU1 1143 cGMP-specific 3',5'-cycli N/A N/A 0.678 0.169 0.285 7e-24
>sp|Q9VJ79|PDE11_DROME Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 OS=Drosophila melanogaster GN=Pde11 PE=1 SV=4 Back     alignment and function desciption
 Score =  205 bits (522), Expect = 3e-52,   Method: Compositional matrix adjust.
 Identities = 135/359 (37%), Positives = 168/359 (46%), Gaps = 120/359 (33%)

Query: 4    DVIAYGSVYRDVKLHDLPSLRVPSAAKLNLHDFKFDDIHMEDDDTLKVA--ELVSSEFFE 61
            +V++Y +     + H L  LRVPSA    LHDFKFDDIH EDDDTLK      +  +F E
Sbjct: 775  EVLSYHASATMDEAHRLRRLRVPSAVHFRLHDFKFDDIHFEDDDTLKACLRMFLDLDFVE 834

Query: 62   QGDIERQELNITPIDIMNREKEDQLPLMQVGF-IDSICLPIYESTQWWKIFGEIECLALL 120
            +  I+ + L    + +    +       +  F +  +   I  +TQWWKIFGEIECLAL+
Sbjct: 835  RFHIDYEVLCRWLLSVKKNYRNVTYHNWRHAFNVAQMMFAILTTTQWWKIFGEIECLALI 894

Query: 121  IACLCHDLDHRGTNNSFQIN-----------------------------------NVSPD 145
            I CLCHDLDHRGTNNSFQI                                    N+S D
Sbjct: 895  IGCLCHDLDHRGTNNSFQIKASSPLAQLYSTSTMEHHHFDQCLMILNSPGNQILANLSSD 954

Query: 146  EYSRIIKVLEEAILSTDLAVYFRQRGSFLSLVKGGSLAWHREADRDLAVYFRQRGSFLSL 205
            +Y R+I+VLE+AILSTDLAVYF++RG FL  V                    Q  S+   
Sbjct: 955  DYCRVIRVLEDAILSTDLAVYFKKRGPFLESVS-------------------QPTSY--- 992

Query: 206  VKGGSLAWHREADRGLLRGMTMTVCDLAAITKPWHVEKR--------------------- 244
                   W  E  R LLR M+MTVCDL+AITKPW +EKR                     
Sbjct: 993  -------WVAEEPRALLRAMSMTVCDLSAITKPWEIEKRVADLVSSEFFEQGDMEKQELN 1045

Query: 245  --------------------------------AFAELSDKLEPLVEGVRSNKQHWLEIA 271
                                            AFA LSDKLEPLVEGVR N+ HW+++A
Sbjct: 1046 ITPIDIMNREKEDELPMMQVNFIDSICLPIYEAFATLSDKLEPLVEGVRDNRGHWIDLA 1104
Plays a role in signal transduction by regulating the intracellular concentration of cyclic nucleotides cAMP and cGMP. Catalyzes the hydrolysis of both cAMP and cGMP to 5'-AMP and 5'-GMP, respectively.
Drosophila melanogaster (taxid: 7227)
EC: 3EC: .EC: 1EC: .EC: 4EC: .EC: 3EC: 5
>sp|B4JXX2|PDE6_DROGR cGMP-specific 3',5'-cyclic phosphodiesterase OS=Drosophila grimshawi GN=Pde6 PE=3 SV=1 Back     alignment and function description
>sp|B4NAL6|PDE6_DROWI cGMP-specific 3',5'-cyclic phosphodiesterase OS=Drosophila willistoni GN=Pde6 PE=3 SV=1 Back     alignment and function description
>sp|B4K9L4|PDE6_DROMO cGMP-specific 3',5'-cyclic phosphodiesterase OS=Drosophila mojavensis GN=Pde6 PE=3 SV=1 Back     alignment and function description
>sp|B4LVU6|PDE6_DROVI cGMP-specific 3',5'-cyclic phosphodiesterase OS=Drosophila virilis GN=Pde6 PE=3 SV=1 Back     alignment and function description
>sp|B4PSS5|PDE6_DROYA cGMP-specific 3',5'-cyclic phosphodiesterase OS=Drosophila yakuba GN=Pde6 PE=3 SV=1 Back     alignment and function description
>sp|Q298P4|PDE6_DROPS cGMP-specific 3',5'-cyclic phosphodiesterase OS=Drosophila pseudoobscura pseudoobscura GN=Pde6 PE=3 SV=3 Back     alignment and function description
>sp|Q9VFI9|PDE6_DROME cGMP-specific 3',5'-cyclic phosphodiesterase OS=Drosophila melanogaster GN=Pde6 PE=1 SV=4 Back     alignment and function description
>sp|B3P3K2|PDE6_DROER cGMP-specific 3',5'-cyclic phosphodiesterase OS=Drosophila erecta GN=Pde6 PE=3 SV=1 Back     alignment and function description
>sp|B4QZU1|PDE6_DROSI cGMP-specific 3',5'-cyclic phosphodiesterase OS=Drosophila simulans GN=Pde6 PE=3 SV=1 Back     alignment and function description

Close Homologs in the Non-Redundant Database Detected by BLAST ?

Original result of BLAST against Nonredundant Database

GI ?Alignment Graph ?Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query286
322794650 625 hypothetical protein SINV_16524 [Solenop 0.804 0.368 0.458 9e-61
383851028 1004 PREDICTED: dual 3',5'-cyclic-AMP and -GM 0.804 0.229 0.422 1e-58
340720331 978 PREDICTED: dual 3',5'-cyclic-AMP and -GM 0.804 0.235 0.422 2e-58
350405537 978 PREDICTED: dual 3',5'-cyclic-AMP and -GM 0.804 0.235 0.42 5e-58
380017646 941 PREDICTED: dual 3',5'-cyclic-AMP and -GM 0.804 0.244 0.42 1e-57
328786557 961 PREDICTED: dual 3',5'-cyclic-AMP and -GM 0.804 0.239 0.42 1e-57
307191290 972 Dual 3',5'-cyclic-AMP and -GMP phosphodi 0.790 0.232 0.401 7e-55
242020583 889 dual 3',5'-cyclic-AMP and -GMP phosphodi 0.779 0.250 0.408 6e-52
307199016 886 Dual 3',5'-cyclic-AMP and -GMP phosphodi 0.790 0.255 0.393 1e-51
195032594 1408 GH10531 [Drosophila grimshawi] gi|193904 0.835 0.169 0.376 5e-51
>gi|322794650|gb|EFZ17657.1| hypothetical protein SINV_16524 [Solenopsis invicta] Back     alignment and taxonomy information
 Score =  239 bits (611), Expect = 9e-61,   Method: Compositional matrix adjust.
 Identities = 145/316 (45%), Positives = 175/316 (55%), Gaps = 86/316 (27%)

Query: 20  LPSLRVPSAAKLNLHDFKFDDIHMEDDDTLKVA--ELVSSEFFEQGDIERQEL------- 70
           L SLR+PS+A   LHDFKFDDIHMED +TL       +  +F E+  I+   L       
Sbjct: 316 LRSLRIPSSAHFELHDFKFDDIHMEDVETLTACLRMFLDLDFVERFHIDYDVLCRWLLSV 375

Query: 71  -----NITPIDIMNREKEDQL--PLMQVGFI--DSICLPIYESTQWWKIFGEIECLALLI 121
                N+T  +  +     Q+   ++ V F    S  + +  +TQWWKIFGEIECLAL+I
Sbjct: 376 KKNYRNVTYHNWRHAFNVAQMMFAILTVSFFLYQSFIIHVSNATQWWKIFGEIECLALII 435

Query: 122 ACLCHDLDHRGTNNSFQI-----------------------------------NNVSPDE 146
           ACLCHDLDHRGTNNSFQI                                   +N+SP+E
Sbjct: 436 ACLCHDLDHRGTNNSFQIKASSPLAQLYSTSTMEHHHFDQCLMILSSQGNQILSNLSPEE 495

Query: 147 YSRIIKVLEEAILSTDLAVYFRQRGSFLSLVKGGSLAWHREADRDLAVYFRQRGSFLSLV 206
           YSR++KVLEEAILSTDLA+YF+ R SFLSL + GS  W                      
Sbjct: 496 YSRVVKVLEEAILSTDLAIYFKNRTSFLSLARSGSYNW---------------------- 533

Query: 207 KGGSLAWHREADRGLLRGMTMTVCDLAAITKPWHVEKR----AFAELSDKLEPLVEGVRS 262
              +   HRE    LLRGM MTVCDLAAITKPW +EKR    AFA LSDKL PLV+GV  
Sbjct: 534 ---AFGEHRE----LLRGMLMTVCDLAAITKPWEIEKRVAELAFAHLSDKLVPLVDGVCK 586

Query: 263 NKQHWLEIAAEKRKQD 278
           NKQHWLEIA  KR+ +
Sbjct: 587 NKQHWLEIAESKRQAE 602

Source: Solenopsis invicta

Species: Solenopsis invicta

Genus: Solenopsis

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota
>gi|383851028|ref|XP_003701055.1| PREDICTED: dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like [Megachile rotundata] Back     alignment and taxonomy information
>gi|340720331|ref|XP_003398594.1| PREDICTED: dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like [Bombus terrestris] Back     alignment and taxonomy information
>gi|350405537|ref|XP_003487467.1| PREDICTED: dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like [Bombus impatiens] Back     alignment and taxonomy information
>gi|380017646|ref|XP_003692760.1| PREDICTED: dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like [Apis florea] Back     alignment and taxonomy information
>gi|328786557|ref|XP_003250812.1| PREDICTED: dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11-like [Apis mellifera] Back     alignment and taxonomy information
>gi|307191290|gb|EFN74937.1| Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 [Camponotus floridanus] Back     alignment and taxonomy information
>gi|242020583|ref|XP_002430732.1| dual 3',5'-cyclic-AMP and -GMP phosphodiesterase, putative [Pediculus humanus corporis] gi|212515922|gb|EEB17994.1| dual 3',5'-cyclic-AMP and -GMP phosphodiesterase, putative [Pediculus humanus corporis] Back     alignment and taxonomy information
>gi|307199016|gb|EFN79740.1| Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11 [Harpegnathos saltator] Back     alignment and taxonomy information
>gi|195032594|ref|XP_001988525.1| GH10531 [Drosophila grimshawi] gi|193904525|gb|EDW03392.1| GH10531 [Drosophila grimshawi] Back     alignment and taxonomy information

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST ?

Original result of BLAST against Gene Ontology (AMIGO)

ID ? Alignment graph ? Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query286
FB|FBgn0085370 1451 Pde11 "Phosphodiesterase 11" [ 0.853 0.168 0.363 8.9e-38
UNIPROTKB|F1NR22832 F1NR22 "Uncharacterized protei 0.192 0.066 0.636 4.3e-24
UNIPROTKB|F1NQH9865 F1NQH9 "Uncharacterized protei 0.192 0.063 0.636 5.1e-24
UNIPROTKB|F1NHB7874 F1NHB7 "Uncharacterized protei 0.192 0.062 0.636 5.3e-24
UNIPROTKB|G5E9C5823 PDE5A "cGMP-specific 3',5'-cyc 0.192 0.066 0.654 6.6e-24
UNIPROTKB|Q28156865 PDE5A "cGMP-specific 3',5'-cyc 0.192 0.063 0.654 8.2e-24
UNIPROTKB|O76074875 PDE5A "cGMP-specific 3',5'-cyc 0.192 0.062 0.654 8.6e-24
UNIPROTKB|O77746865 PDE5A "cGMP-specific 3',5'-cyc 0.192 0.063 0.654 1e-23
UNIPROTKB|F1S1S7741 PDE5A "Uncharacterized protein 0.192 0.074 0.654 1.3e-23
ZFIN|ZDB-GENE-060824-4868 pde5ab "phosphodiesterase 5A, 0.192 0.063 0.690 1.6e-23
FB|FBgn0085370 Pde11 "Phosphodiesterase 11" [Drosophila melanogaster (taxid:7227)] Back     alignment and assigned GO terms
 Score = 336 (123.3 bits), Expect = 8.9e-38, Sum P(2) = 8.9e-38
 Identities = 93/256 (36%), Positives = 122/256 (47%)

Query:     4 DVIAY-GSVYRDVKLHDLPSLRVPSAAKLNLHDFKFDDIHMEDDDTLKVA--ELVSSEFF 60
             +V++Y  S   D + H L  LRVPSA    LHDFKFDDIH EDDDTLK      +  +F 
Sbjct:   775 EVLSYHASATMD-EAHRLRRLRVPSAVHFRLHDFKFDDIHFEDDDTLKACLRMFLDLDFV 833

Query:    61 EQGDIERQELNITPIDIMNREKEDQLPLMQVGF-IDSICLPIYESTQWWKIFGXXXXXXX 119
             E+  I+ + L    + +    +       +  F +  +   I  +TQWWKIFG       
Sbjct:   834 ERFHIDYEVLCRWLLSVKKNYRNVTYHNWRHAFNVAQMMFAILTTTQWWKIFGEIECLAL 893

Query:   120 XXXXXXXXXXXRGTNNSFQINNVSPDEYSRIIKVLEEAILSTDLAVYFRQRGSFLSLVKG 179
                        RGTNNSFQI   SP         +E       L +        L+ +  
Sbjct:   894 IIGCLCHDLDHRGTNNSFQIKASSPLAQLYSTSTMEHHHFDQCLMILNSPGNQILANLSS 953

Query:   180 GS----LAWHREA--DRDLAVYFRQRGSFLSLVKGGSLAWHREADRGLLRGMTMTVCDLA 233
                   +    +A    DLAVYF++RG FL  V   +  W  E  R LLR M+MTVCDL+
Sbjct:   954 DDYCRVIRVLEDAILSTDLAVYFKKRGPFLESVSQPTSYWVAEEPRALLRAMSMTVCDLS 1013

Query:   234 AITKPWHVEKRAFAEL 249
             AITKPW +EKR  A+L
Sbjct:  1014 AITKPWEIEKRV-ADL 1028
GO:0047555 "3',5'-cyclic-GMP phosphodiesterase activity" evidence=ISS;IDA
GO:0005575 "cellular_component" evidence=ND
GO:0004115 "3',5'-cyclic-AMP phosphodiesterase activity" evidence=ISS;IDA
GO:0007165 "signal transduction" evidence=IEA
GO:0046058 "cAMP metabolic process" evidence=IDA
GO:0046068 "cGMP metabolic process" evidence=IDA
GO:0046331 "lateral inhibition" evidence=IMP
UNIPROTKB|F1NR22 F1NR22 "Uncharacterized protein" [Gallus gallus (taxid:9031)] Back     alignment and assigned GO terms
UNIPROTKB|F1NQH9 F1NQH9 "Uncharacterized protein" [Gallus gallus (taxid:9031)] Back     alignment and assigned GO terms
UNIPROTKB|F1NHB7 F1NHB7 "Uncharacterized protein" [Gallus gallus (taxid:9031)] Back     alignment and assigned GO terms
UNIPROTKB|G5E9C5 PDE5A "cGMP-specific 3',5'-cyclic phosphodiesterase" [Homo sapiens (taxid:9606)] Back     alignment and assigned GO terms
UNIPROTKB|Q28156 PDE5A "cGMP-specific 3',5'-cyclic phosphodiesterase" [Bos taurus (taxid:9913)] Back     alignment and assigned GO terms
UNIPROTKB|O76074 PDE5A "cGMP-specific 3',5'-cyclic phosphodiesterase" [Homo sapiens (taxid:9606)] Back     alignment and assigned GO terms
UNIPROTKB|O77746 PDE5A "cGMP-specific 3',5'-cyclic phosphodiesterase" [Canis lupus familiaris (taxid:9615)] Back     alignment and assigned GO terms
UNIPROTKB|F1S1S7 PDE5A "Uncharacterized protein" [Sus scrofa (taxid:9823)] Back     alignment and assigned GO terms
ZFIN|ZDB-GENE-060824-4 pde5ab "phosphodiesterase 5A, cGMP-specific, b" [Danio rerio (taxid:7955)] Back     alignment and assigned GO terms

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries ?

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by EFICAz Software ?

Prediction LevelEC numberConfidence of Prediction
3rd Layer3.1.4.17LOW CONFIDENCE prediction!
3rd Layer3.1.4LOW CONFIDENCE prediction!

Prediction of Functionally Associated Proteins

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST ?

Original result of RPS-BLAST against CDD database

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query286
pfam00233237 pfam00233, PDEase_I, 3'5'-cyclic nucleotide phosph 3e-17
pfam00233237 pfam00233, PDEase_I, 3'5'-cyclic nucleotide phosph 2e-08
>gnl|CDD|109297 pfam00233, PDEase_I, 3'5'-cyclic nucleotide phosphodiesterase Back     alignment and domain information 
 Score = 78.6 bits (194), Expect = 3e-17
 Identities = 41/170 (24%), Positives = 66/170 (38%), Gaps = 67/170 (39%)

Query: 111 FGEIECLALLIACLCHDLDHRGTNNSFQIN------------------------------ 140
             ++E LALL A   HD+DHRGTNNSFQIN                              
Sbjct: 27  LTDLEILALLFAAAIHDVDHRGTNNSFQINSKSELAILYNDESVLENHHLAQAFKLLQDE 86

Query: 141 ------NVSPDEYSRIIKVLEEAILSTDLAVYFRQRGSFLSLVKGGSLAWHREADRDLAV 194
                 N+S  ++  +  ++ E IL+TD++++F++     ++V+       +  D D   
Sbjct: 87  ECNIFQNLSKKDFQTLRDLVIEMILATDMSLHFQKLKDLKTMVEQK-----KRLDLD--- 138

Query: 195 YFRQRGSFLSLVKGGSLAWHREADRGLLRGMTMTVCDLAAITKPWHVEKR 244
                                   + LL  + M   DL+  TKPW + +R
Sbjct: 139 -----------------------HKILLLSLLMHAADLSNPTKPWKLHRR 165

Length = 237
>gnl|CDD|109297 pfam00233, PDEase_I, 3'5'-cyclic nucleotide phosphodiesterase Back     alignment and domain information

Conserved Domains Detected by HHsearch ?

Original result of HHsearch against CDD database

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query 286
KOG3689|consensus707 100.0
KOG3688|consensus 554 100.0
PF00233237 PDEase_I: 3'5'-cyclic nucleotide phosphodiesterase 100.0
KOG1229|consensus775 100.0
KOG3689|consensus707 98.03
PF00233237 PDEase_I: 3'5'-cyclic nucleotide phosphodiesterase 97.09
KOG3688|consensus554 96.54
cd00077145 HDc Metal dependent phosphohydrolases with conserv 94.99
TIGR01353 381 dGTP_triPase deoxyguanosinetriphosphate triphospho 92.46
smart00471124 HDc Metal dependent phosphohydrolases with conserv 92.01
COG0232 412 Dgt dGTP triphosphohydrolase [Nucleotide transport 91.98
PRK01286336 deoxyguanosinetriphosphate triphosphohydrolase-lik 89.77
KOG2681|consensus 498 89.59
PRK03007 428 deoxyguanosinetriphosphate triphosphohydrolase-lik 88.52
PRK01096 440 deoxyguanosinetriphosphate triphosphohydrolase-lik 87.31
COG2206344 c-di-GMP phosphodiesterase class II (HD-GYP domain 87.26
COG1078 421 HD superfamily phosphohydrolases [General function 87.17
PRK04926 503 dgt deoxyguanosinetriphosphate triphosphohydrolase 85.78
PRK05318 432 deoxyguanosinetriphosphate triphosphohydrolase-lik 85.42
PF01966122 HD: HD domain; InterPro: IPR006674 This domain is 84.81
>KOG3689|consensus Back     alignment and domain information 
Probab=100.00  E-value=6.8e-56  Score=444.38  Aligned_cols=229  Identities=32%  Similarity=0.570  Sum_probs=216.4

Q ss_pred             CchhhhhhcCccChHHHhcCCCCCCChhhhcCCCCCCCCCccCCchhhhhHHHHHHHHHhhcCchhhhcC----------
Q psy14371          1 MNYDVIAYGSVYRDVKLHDLPSLRVPSAAKLNLHDFKFDDIHMEDDDTLKVAELVSSEFFEQGDIERQEL----------   70 (286)
Q Consensus         1 ~~~e~~~y~~~~~~~e~~~l~~~~~p~~~~~~l~~w~Fd~~~l~~~e~~~~~~~i~~~F~~~g~lekf~i----------   70 (286)
                      +++|+++||++|.++|++.+     | +....+.+|.|+++.+++.++..+++.   ||.++|++++|+|          
T Consensus       348 v~~e~l~~h~~~~~~e~~~~-----~-~~~~~l~d~~f~d~~~~~~~l~~~~~~---mf~~l~lv~~f~I~~~tL~r~ll  418 (707)
T KOG3689|consen  348 VALEFLSYHAKALEEEVQWG-----P-ATILKLLDFFFSDRLLSENELTKCTFR---MFQDLGLVKKFKIDVETLCRFLL  418 (707)
T ss_pred             hhHHHHHHHHhhhHHhhccc-----c-hhhhccccceeccccCCCchHHHHHHH---HHHHcCcceeeccCHHHHHHHHh
Confidence            46899999999999999999     5 566789999999999999999999887   9999999999987          


Q ss_pred             ----CCC-CCCCCCccccCCccccccccccccccccccccchhhhhchHHHHHHHHHHHhccCCCCCCCCccccc-----
Q psy14371         71 ----NIT-PIDIMNREKEDQLPLMQVGFIDSICLPIYESTQWWKIFGEIECLALLIACLCHDLDHRGTNNSFQIN-----  140 (286)
Q Consensus        71 ----~Y~-~~pyHN~~~~Ha~~v~Q~~f~~~~~~~l~~~~~l~~~l~~~e~lalliaal~HDvdH~G~nN~f~~~-----  140 (286)
                          +|+ +||||||.  ||++|+|      +++.+++.+.+...|+++|++|+++||+|||+||||+||.|+++     
T Consensus       419 tV~k~Yr~~v~YHNw~--HAf~VaQ------~m~~lL~t~~L~~~fTdlEiLalliAalcHDlDHrGtNN~f~iks~s~L  490 (707)
T KOG3689|consen  419 TVEKNYRSNVPYHNWR--HAFDVAQ------AMFALLKTPKLQNKFTDLEILALLIAALCHDLDHRGTNNSYLIKSNSPL  490 (707)
T ss_pred             hhhhccccCCcchhHH--HHHHHHH------HHHHHHhchhHHhhcChHHHHHHHHHHHHccCCCCCCCcHHHHhcCCHH
Confidence                488 99999999  9999999      99999999999999999999999999999999999999999998     


Q ss_pred             -------------------------------CCCHHHHHHHHHHHHHHHHhcchhhHHHHHHHHHHHHhCCCcccccccc
Q psy14371        141 -------------------------------NVSPDEYSRIIKVLEEAILSTDLAVYFRQRGSFLSLVKGGSLAWHREAD  189 (286)
Q Consensus       141 -------------------------------~L~~~~~~~~r~~ii~~ILATDMa~Hf~~~~~f~~~~~~~~~~~~~~~~  189 (286)
                                                     ||++++|++++++|+++|||||||+||+++++|++.+..+         
T Consensus       491 A~lY~~~SvLE~HH~~~~~~lLqe~~~nIfsnLs~~~~~~~~~~i~~~ILATDla~h~~~~~~lk~~v~~~---------  561 (707)
T KOG3689|consen  491 AQLYNDSSVLENHHFAQAFKLLQEEGCNIFSNLSKKQYQQIRKLIIDAILATDLALHFKKRADLKEMVETK---------  561 (707)
T ss_pred             HHHhCCccHHHHHHHHHHHHHHhccccchhhcCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcc---------
Confidence                                           8999999999999999999999999999999999998763         


Q ss_pred             hhhhHhhhccccccccccCCCCCCCChhhHHHHHHHhhhhccCcCCCCChHHHHH-------------------------
Q psy14371        190 RDLAVYFRQRGSFLSLVKGGSLAWHREADRGLLRGMTMTVCDLAAITKPWHVEKR-------------------------  244 (286)
Q Consensus       190 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~r~ll~~~ii~~aDisn~~kp~~v~~k-------------------------  244 (286)
                                         +.|++.+++||.++++|+||||||||+||||+++++                         
T Consensus       562 -------------------~~~~~~~~~hr~lvl~mmmtacDLSn~TKpwei~~qwa~~I~~EFf~QGDeek~lg~~p~p  622 (707)
T KOG3689|consen  562 -------------------GVYDLENYSHRILVLAMMMTACDLSNPTKPWEIQKQWAELIAEEFFDQGDEEKELGLEPSP  622 (707)
T ss_pred             -------------------CcccccchhHHHHHHHHHHHHhhccCCcCCccHHHHHHHHHHHHHHhcchHHHHcCCCCCc
Confidence                               268889999999999999999999999999999999                         


Q ss_pred             --------------------------HHHHHccChHHHHHHHHHHHHHHHHHHHHH
Q psy14371        245 --------------------------AFAELSDKLEPLVEGVRSNKQHWLEIAAEK  274 (286)
Q Consensus       245 --------------------------~~a~~~p~~~~~~~~~~~N~~~W~~~~~~~  274 (286)
                                                ++++++|+.+|+++++..||..|++++++.
T Consensus       623 mmDR~k~~vp~~QvgFid~I~~Plyet~a~l~~~~~pmld~l~~Nr~~w~~l~~~~  678 (707)
T KOG3689|consen  623 MMDRDKASVPKLQVGFIDYICIPLYETWADLVPDAQPMLDGLEDNREWWQSLIPES  678 (707)
T ss_pred             ccccCcccCchhhhhHHHHHHHHHHHHHHHhccchhhHHHHHHHhHHHHHHhhhhh
Confidence                                      689999999999999999999999999733

>KOG3688|consensus Back     alignment and domain information
>PF00233 PDEase_I: 3'5'-cyclic nucleotide phosphodiesterase; InterPro: IPR002073 The cyclic nucleotide phosphodiesterases (PDE) comprise a group of enzymes that degrade the phosphodiester bond in the second messenger molecules cAMP and cGMP Back     alignment and domain information
>KOG1229|consensus Back     alignment and domain information
>KOG3689|consensus Back     alignment and domain information
>PF00233 PDEase_I: 3'5'-cyclic nucleotide phosphodiesterase; InterPro: IPR002073 The cyclic nucleotide phosphodiesterases (PDE) comprise a group of enzymes that degrade the phosphodiester bond in the second messenger molecules cAMP and cGMP Back     alignment and domain information
>KOG3688|consensus Back     alignment and domain information
>cd00077 HDc Metal dependent phosphohydrolases with conserved 'HD' motif Back     alignment and domain information
>TIGR01353 dGTP_triPase deoxyguanosinetriphosphate triphosphohydrolase, putative Back     alignment and domain information
>smart00471 HDc Metal dependent phosphohydrolases with conserved 'HD' motif Back     alignment and domain information
>COG0232 Dgt dGTP triphosphohydrolase [Nucleotide transport and metabolism] Back     alignment and domain information
>PRK01286 deoxyguanosinetriphosphate triphosphohydrolase-like protein; Provisional Back     alignment and domain information
>KOG2681|consensus Back     alignment and domain information
>PRK03007 deoxyguanosinetriphosphate triphosphohydrolase-like protein; Provisional Back     alignment and domain information
>PRK01096 deoxyguanosinetriphosphate triphosphohydrolase-like protein; Provisional Back     alignment and domain information
>COG2206 c-di-GMP phosphodiesterase class II (HD-GYP domain) [Signal transduction mechanisms] Back     alignment and domain information
>COG1078 HD superfamily phosphohydrolases [General function prediction only] Back     alignment and domain information
>PRK04926 dgt deoxyguanosinetriphosphate triphosphohydrolase; Provisional Back     alignment and domain information
>PRK05318 deoxyguanosinetriphosphate triphosphohydrolase-like protein; Provisional Back     alignment and domain information
>PF01966 HD: HD domain; InterPro: IPR006674 This domain is found in a superfamily of enzymes with a predicted or known phosphohydrolase activity [] Back     alignment and domain information

Homologous Structure Templates

Structure Templates Detected by BLAST ?

Original result of BLAST against Protein Data Bank

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query286
1t9r_A366 Catalytic Domain Of Human Phosphodiesterase 5a Leng 2e-17
1t9r_A366 Catalytic Domain Of Human Phosphodiesterase 5a Leng 5e-09
3b2r_A330 Crystal Structure Of Pde5a1 Catalytic Domain In Com 2e-17
3b2r_A330 Crystal Structure Of Pde5a1 Catalytic Domain In Com 4e-09
1udt_A324 Crystal Structure Of Human Phosphodiesterase 5 Comp 2e-17
1udt_A324 Crystal Structure Of Human Phosphodiesterase 5 Comp 4e-09
2h40_A326 Crystal Structure Of The Catalytic Domain Of Unliga 2e-17
2h40_A326 Crystal Structure Of The Catalytic Domain Of Unliga 4e-09
3hc8_A324 Investigation Of Aminopyridiopyrazinones As Pde5 In 2e-17
3hc8_A324 Investigation Of Aminopyridiopyrazinones As Pde5 In 8e-10
1xoz_A364 Catalytic Domain Of Human Phosphodiesterase 5a In C 2e-17
1xoz_A364 Catalytic Domain Of Human Phosphodiesterase 5a In C 4e-09
3shy_A347 Crystal Structure Of The Pde5a1 Catalytic Domain In 2e-17
3shy_A347 Crystal Structure Of The Pde5a1 Catalytic Domain In 5e-09
1t9s_A347 Catalytic Domain Of Human Phosphodiesterase 5a In C 2e-17
1t9s_A347 Catalytic Domain Of Human Phosphodiesterase 5a In C 5e-09
2chm_A326 Crystal Structure Of N2 Substituted Pyrazolo Pyrimi 2e-17
2chm_A326 Crystal Structure Of N2 Substituted Pyrazolo Pyrimi 8e-10
3bjc_A878 Crystal Structure Of The Pde5a Catalytic Domain In 2e-17
3bjc_A878 Crystal Structure Of The Pde5a Catalytic Domain In 5e-09
1rkp_A326 Crystal Structure Of Pde5a1-Ibmx Length = 326 3e-17
1rkp_A326 Crystal Structure Of Pde5a1-Ibmx Length = 326 3e-09
3jwq_A330 Crystal Structure Of Chimeric Pde5/pde6 Catalytic D 1e-12
3jwq_A330 Crystal Structure Of Chimeric Pde5/pde6 Catalytic D 4e-09
1z1l_A345 The Crystal Structure Of The Phosphodiesterase 2a C 1e-07
3itm_A345 Catalytic Domain Of Hpde2a Length = 345 1e-07
3ibj_A691 X-Ray Structure Of Pde2a Length = 691 2e-07
3lxg_A308 Crystal Structure Of Rat Phosphodiesterase 10a In C 1e-06
3hqw_A376 Discovery Of Novel Inhibitors Of Pde10a Length = 37 2e-06
2o8h_A362 Crystal Structure Of The Catalytic Domain Of Rat Ph 2e-06
3hqy_A380 Discovery Of Novel Inhibitors Of Pde10a Length = 38 2e-06
2our_A331 Crystal Structure Of Pde10a2 Mutant D674a In Comple 3e-06
4dff_A352 The Sar Development Of Dihydroimidazoisoquinoline D 1e-05
4dff_A352 The Sar Development Of Dihydroimidazoisoquinoline D 1e-05
4ddl_A338 Pde10a Crystal Structure Complexed With Novel Inhib 1e-05
4ddl_A338 Pde10a Crystal Structure Complexed With Novel Inhib 1e-05
4ael_A344 Pde10a In Complex With The Inhibitor Az5 Length = 3 1e-05
4ael_A344 Pde10a In Complex With The Inhibitor Az5 Length = 3 1e-05
3sn7_A345 Highly Potent, Selective, And Orally Active Phospho 1e-05
3sn7_A345 Highly Potent, Selective, And Orally Active Phospho 1e-05
2wey_A343 Human Pde-Papaverine Complex Obtained By Ligand Soa 1e-05
2wey_A343 Human Pde-Papaverine Complex Obtained By Ligand Soa 1e-05
4heu_A318 Crystal Structure Of Pde10a With A Biaryl Ether Inh 1e-05
3ui7_A333 Discovery Of Orally Active Pyrazoloquinoline As A P 1e-05
3uuo_A337 The Discovery Of Potent, Selectivity, And Orally Bi 1e-05
2ouv_A331 Crystal Structure Of Pde10a2 Mutant Of D564n Length 1e-05
2ouv_A331 Crystal Structure Of Pde10a2 Mutant Of D564n Length 1e-05
2oun_A331 Crystal Structure Of Pde10a2 In Complex With Amp Le 1e-05
2oun_A331 Crystal Structure Of Pde10a2 In Complex With Amp Le 1e-05
2y0j_A340 Triazoloquinazolines As A Novel Class Of Phosphodie 1e-05
2y0j_A340 Triazoloquinazolines As A Novel Class Of Phosphodie 1e-05
>pdb|1T9R|A Chain A, Catalytic Domain Of Human Phosphodiesterase 5a Length = 366 Back     alignment and structure 
Iteration: 1

 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 36/55 (65%), Positives = 50/55 (90%)
Query: 50  KVAELVSSEFFEQGDIERQELNITPIDIMNREKEDQLPLMQVGFIDSICLPIYES 104
           ++AELV++EFF+QGD ER+ELNI P D+MNREK++++P MQVGFID+ICL +YE+
Sbjct: 268 RIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEA 322
>pdb|1T9R|A Chain A, Catalytic Domain Of Human Phosphodiesterase 5a Length = 366 Back     alignment and structure
>pdb|3B2R|A Chain A, Crystal Structure Of Pde5a1 Catalytic Domain In Complex With Vardenafil Length = 330 Back     alignment and structure
>pdb|3B2R|A Chain A, Crystal Structure Of Pde5a1 Catalytic Domain In Complex With Vardenafil Length = 330 Back     alignment and structure
>pdb|1UDT|A Chain A, Crystal Structure Of Human Phosphodiesterase 5 Complexed With Sildenafil(Viagra) Length = 324 Back     alignment and structure
>pdb|1UDT|A Chain A, Crystal Structure Of Human Phosphodiesterase 5 Complexed With Sildenafil(Viagra) Length = 324 Back     alignment and structure
>pdb|2H40|A Chain A, Crystal Structure Of The Catalytic Domain Of Unliganded Pde5 Length = 326 Back     alignment and structure
>pdb|2H40|A Chain A, Crystal Structure Of The Catalytic Domain Of Unliganded Pde5 Length = 326 Back     alignment and structure
>pdb|3HC8|A Chain A, Investigation Of Aminopyridiopyrazinones As Pde5 Inhibitors: Evaluation Of Modifications To The Central Ring System. Length = 324 Back     alignment and structure
>pdb|3HC8|A Chain A, Investigation Of Aminopyridiopyrazinones As Pde5 Inhibitors: Evaluation Of Modifications To The Central Ring System. Length = 324 Back     alignment and structure
>pdb|1XOZ|A Chain A, Catalytic Domain Of Human Phosphodiesterase 5a In Complex With Tadalafil Length = 364 Back     alignment and structure
>pdb|1XOZ|A Chain A, Catalytic Domain Of Human Phosphodiesterase 5a In Complex With Tadalafil Length = 364 Back     alignment and structure
>pdb|3SHY|A Chain A, Crystal Structure Of The Pde5a1 Catalytic Domain In Complex With Novel Inhibitors Length = 347 Back     alignment and structure
>pdb|3SHY|A Chain A, Crystal Structure Of The Pde5a1 Catalytic Domain In Complex With Novel Inhibitors Length = 347 Back     alignment and structure
>pdb|1T9S|A Chain A, Catalytic Domain Of Human Phosphodiesterase 5a In Complex With Gmp Length = 347 Back     alignment and structure
>pdb|1T9S|A Chain A, Catalytic Domain Of Human Phosphodiesterase 5a In Complex With Gmp Length = 347 Back     alignment and structure
>pdb|2CHM|A Chain A, Crystal Structure Of N2 Substituted Pyrazolo Pyrimidinones- A Flipped Binding Mode In Pde5 Length = 326 Back     alignment and structure
>pdb|2CHM|A Chain A, Crystal Structure Of N2 Substituted Pyrazolo Pyrimidinones- A Flipped Binding Mode In Pde5 Length = 326 Back     alignment and structure
>pdb|3BJC|A Chain A, Crystal Structure Of The Pde5a Catalytic Domain In Complex With A Novel Inhibitor Length = 878 Back     alignment and structure
>pdb|3BJC|A Chain A, Crystal Structure Of The Pde5a Catalytic Domain In Complex With A Novel Inhibitor Length = 878 Back     alignment and structure
>pdb|1RKP|A Chain A, Crystal Structure Of Pde5a1-Ibmx Length = 326 Back     alignment and structure
>pdb|1RKP|A Chain A, Crystal Structure Of Pde5a1-Ibmx Length = 326 Back     alignment and structure
>pdb|3JWQ|A Chain A, Crystal Structure Of Chimeric Pde5/pde6 Catalytic Domain Complexed With Sildenafil Length = 330 Back     alignment and structure
>pdb|3JWQ|A Chain A, Crystal Structure Of Chimeric Pde5/pde6 Catalytic Domain Complexed With Sildenafil Length = 330 Back     alignment and structure
>pdb|1Z1L|A Chain A, The Crystal Structure Of The Phosphodiesterase 2a Catalytic Domain Length = 345 Back     alignment and structure
>pdb|3ITM|A Chain A, Catalytic Domain Of Hpde2a Length = 345 Back     alignment and structure
>pdb|3IBJ|A Chain A, X-Ray Structure Of Pde2a Length = 691 Back     alignment and structure
>pdb|3LXG|A Chain A, Crystal Structure Of Rat Phosphodiesterase 10a In Complex Wi Web-3 Length = 308 Back     alignment and structure
>pdb|3HQW|A Chain A, Discovery Of Novel Inhibitors Of Pde10a Length = 376 Back     alignment and structure
>pdb|2O8H|A Chain A, Crystal Structure Of The Catalytic Domain Of Rat Phosphodiesterase 10a Length = 362 Back     alignment and structure
>pdb|3HQY|A Chain A, Discovery Of Novel Inhibitors Of Pde10a Length = 380 Back     alignment and structure
>pdb|2OUR|A Chain A, Crystal Structure Of Pde10a2 Mutant D674a In Complex With Camp Length = 331 Back     alignment and structure
>pdb|4DFF|A Chain A, The Sar Development Of Dihydroimidazoisoquinoline Derivatives As Phosphodiesterase 10a Inhibitors For The Treatment Of Schizophrenia Length = 352 Back     alignment and structure
>pdb|4DFF|A Chain A, The Sar Development Of Dihydroimidazoisoquinoline Derivatives As Phosphodiesterase 10a Inhibitors For The Treatment Of Schizophrenia Length = 352 Back     alignment and structure
>pdb|4DDL|A Chain A, Pde10a Crystal Structure Complexed With Novel Inhibitor Length = 338 Back     alignment and structure
>pdb|4DDL|A Chain A, Pde10a Crystal Structure Complexed With Novel Inhibitor Length = 338 Back     alignment and structure
>pdb|4AEL|A Chain A, Pde10a In Complex With The Inhibitor Az5 Length = 344 Back     alignment and structure
>pdb|4AEL|A Chain A, Pde10a In Complex With The Inhibitor Az5 Length = 344 Back     alignment and structure
>pdb|3SN7|A Chain A, Highly Potent, Selective, And Orally Active Phosphodiestarase 10a Inhibitors Length = 345 Back     alignment and structure
>pdb|3SN7|A Chain A, Highly Potent, Selective, And Orally Active Phosphodiestarase 10a Inhibitors Length = 345 Back     alignment and structure
>pdb|2WEY|A Chain A, Human Pde-Papaverine Complex Obtained By Ligand Soaking Of Cross-Linked Protein Crystals Length = 343 Back     alignment and structure
>pdb|2WEY|A Chain A, Human Pde-Papaverine Complex Obtained By Ligand Soaking Of Cross-Linked Protein Crystals Length = 343 Back     alignment and structure
>pdb|4HEU|A Chain A, Crystal Structure Of Pde10a With A Biaryl Ether Inhibitor ((1-(3-(4- ((1h-Benzo[d]imidazol-2-Yl)amino)phenoxy)pyridin-2- Yl)piperidin-4- Yl)methanol) Length = 318 Back     alignment and structure
>pdb|3UI7|A Chain A, Discovery Of Orally Active Pyrazoloquinoline As A Potent Pde10 Inhibitor For The Management Of Schizophrenia Length = 333 Back     alignment and structure
>pdb|3UUO|A Chain A, The Discovery Of Potent, Selectivity, And Orally Bioavailable Pyrozoloquinolines As Pde10 Inhibitors For The Treatment Of Schizophrenia Length = 337 Back     alignment and structure
>pdb|2OUV|A Chain A, Crystal Structure Of Pde10a2 Mutant Of D564n Length = 331 Back     alignment and structure
>pdb|2OUV|A Chain A, Crystal Structure Of Pde10a2 Mutant Of D564n Length = 331 Back     alignment and structure
>pdb|2OUN|A Chain A, Crystal Structure Of Pde10a2 In Complex With Amp Length = 331 Back     alignment and structure
>pdb|2OUN|A Chain A, Crystal Structure Of Pde10a2 In Complex With Amp Length = 331 Back     alignment and structure
>pdb|2Y0J|A Chain A, Triazoloquinazolines As A Novel Class Of Phosphodiesterase 10a (Pde10a) Inhibitors, Part 2, Lead-Optimisation. Length = 340 Back     alignment and structure
>pdb|2Y0J|A Chain A, Triazoloquinazolines As A Novel Class Of Phosphodiesterase 10a (Pde10a) Inhibitors, Part 2, Lead-Optimisation. Length = 340 Back     alignment and structure

Structure Templates Detected by RPS-BLAST ?

Original result of RPS-BLAST against PDB70 database

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query286
1tbf_A347 CGMP-specific 3',5'-cyclic phosphodiesterase; PDE5 5e-31
3v93_A345 Cyclic nucleotide specific phosphodiesterase; para 4e-30
2our_A331 CAMP and CAMP-inhibited CGMP 3',5'-cyclic phosphod 6e-30
1zkl_A353 HCP1, TM22, high-affinity CAMP-specific 3',5'-cycl 3e-29
1zkl_A353 HCP1, TM22, high-affinity CAMP-specific 3',5'-cycl 3e-14
3itu_A345 CGMP-dependent 3',5'-cyclic phosphodiesterase; Zn- 7e-29
3ecm_A338 High affinity CAMP-specific and IBMX-insensitive 3 1e-28
3ecm_A338 High affinity CAMP-specific and IBMX-insensitive 3 1e-13
3hr1_A380 CAMP and CAMP-inhibited CGMP 3',5'-cyclic phosphod 2e-28
1y2k_A349 DPDE3, PDE43, CAMP-specific 3',5'-cyclic phosphodi 2e-28
1y2k_A349 DPDE3, PDE43, CAMP-specific 3',5'-cyclic phosphodi 3e-14
1f0j_A377 PDE4B, phosphodiesterase 4B; PDE phosphodiesterase 7e-28
1f0j_A377 PDE4B, phosphodiesterase 4B; PDE phosphodiesterase 3e-13
3g4g_A421 DPDE3, PDE43, CAMP-specific 3',5'-cyclic phosphodi 2e-27
3g4g_A421 DPDE3, PDE43, CAMP-specific 3',5'-cyclic phosphodi 4e-13
3qi3_A533 High affinity CGMP-specific 3',5'-cyclic phosphod 2e-26
3dyn_A329 High affinity CGMP-specific 3',5'-cyclic phosphod 2e-26
3bjc_A878 CGMP-specific 3',5'-cyclic phosphodiesterase; PDE5 8e-26
3bjc_A878 CGMP-specific 3',5'-cyclic phosphodiesterase; PDE5 6e-18
1so2_A420 CGMP-inhibited 3',5'-cyclic phosphodiesterase B; P 4e-25
1so2_A420 CGMP-inhibited 3',5'-cyclic phosphodiesterase B; P 8e-14
3ibj_A691 CGMP-dependent 3',5'-cyclic phosphodiesterase; PDE 8e-25
3ibj_A691 CGMP-dependent 3',5'-cyclic phosphodiesterase; PDE 7e-16
2r8q_A359 Class I phosphodiesterase PDEB1; leishimaniasis, p 1e-24
1taz_A365 Calcium/calmodulin-dependent 3',5'-cyclic nucleot 2e-24
1taz_A365 Calcium/calmodulin-dependent 3',5'-cyclic nucleot 4e-14
>1tbf_A CGMP-specific 3',5'-cyclic phosphodiesterase; PDE5A, hydrolase; HET: VIA; 1.30A {Homo sapiens} SCOP: a.211.1.2 PDB: 1t9s_A* 1xoz_A* 1xp0_A* 2chm_A* 3tge_A* 3tgg_A* 3hc8_A* 3hdz_A* 1t9r_A* 3sie_A* 3shy_A* 3shz_A* 3b2r_A* 2h44_A* 2h42_A* 2h40_A* 1rkp_A* 1udt_A* 1udu_A* 1uho_A* ... Length = 347 Back     alignment and structure
 Score =  117 bits (295), Expect = 5e-31
 Identities = 74/379 (19%), Positives = 118/379 (31%), Gaps = 158/379 (41%)

Query: 4   DVIAYGSVYRDVKLHDLPSLRVPSAAKLNLHDFKFDDIHMEDDDTLKVAELVSSEFFEQG 63
                       +L  L +  VPSA  L + DF F D  + D +T      +   F +  
Sbjct: 15  VPRGSHMEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRM---FTDLN 71

Query: 64  DIERQELNITPIDIMNREKEDQLPLMQVGFIDSI----------------------CLPI 101
            ++     +    +               +I S+                          
Sbjct: 72  LVQN--FQMKHEVLCR-------------WILSVKKNYRKNVAYHNWRHAFNTAQCMFAA 116

Query: 102 YESTQWWKIFGEIECLALLIACLCHDLDHRGTNNSFQIN--------------------- 140
            ++ +      ++E LALLIA L HDLDH G +N F IN                     
Sbjct: 117 LKAGKIQNKLTDLEILALLIAALSHDLDHPGVSNQFLINTNSELALMYNDESVLEHHHFD 176

Query: 141 ---------------NVSPDEYSRIIKVLEEAILSTDLAVYFRQRGSFLSLVKGGSLAWH 185
                           +S +EY   +K++++AIL+TDLA+Y ++RG F  L++       
Sbjct: 177 QCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKNQFNLE 236

Query: 186 READRDLAVYFRQRGSFLSLVKGGSLAWHREADRGLLRGMTMTVCDLAAITKPWHVEKR- 244
               ++L                                M MT CDL+AITKPW +++R 
Sbjct: 237 DPHQKEL-----------------------------FLAMLMTACDLSAITKPWPIQQRI 267

Query: 245 ----------------------------------------------------AFAELSDK 252
                                                               A   +S+ 
Sbjct: 268 AELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSED 327

Query: 253 LEPLVEGVRSNKQHWLEIA 271
             PL++G R N+Q W  +A
Sbjct: 328 CFPLLDGCRKNRQKWQALA 346
>3v93_A Cyclic nucleotide specific phosphodiesterase; parasite, phosphodiesterases,, hydrolase; 2.00A {Trypanosoma cruzi} PDB: 3v94_A* Length = 345 Back     alignment and structure
>2our_A CAMP and CAMP-inhibited CGMP 3',5'-cyclic phosphodiesterase 10A; PDE10, substrate specificity, hydrolase; HET: CMP; 1.45A {Homo sapiens} PDB: 2ous_A 2ouu_A* 3sn7_A* 3sni_A* 3snl_A* 4dff_A* 2wey_A* 2oun_A* 2oup_A 2ouq_A* 2ouv_A 2ouy_A* 4ael_A* 2y0j_A* 4ddl_A* 3uuo_A* 3ui7_A* 2o8h_A* 2ovv_A* 2ovy_A* ... Length = 331 Back     alignment and structure
>1zkl_A HCP1, TM22, high-affinity CAMP-specific 3',5'-cyclic phosphodiesterase 7A; PDE, hydrolase; HET: IBM; 1.67A {Homo sapiens} PDB: 3g3n_A* Length = 353 Back     alignment and structure
>1zkl_A HCP1, TM22, high-affinity CAMP-specific 3',5'-cyclic phosphodiesterase 7A; PDE, hydrolase; HET: IBM; 1.67A {Homo sapiens} PDB: 3g3n_A* Length = 353 Back     alignment and structure
>3itu_A CGMP-dependent 3',5'-cyclic phosphodiesterase; Zn-binding, all-alpha-helical, alternative splicing, hydrolase, membrane, polymorphism; HET: IBM; 1.58A {Homo sapiens} PDB: 3itm_A* 1z1l_A Length = 345 Back     alignment and structure
>3ecm_A High affinity CAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A...; phosphodiesterase 8A PDE8A inhibitor selectivity; 1.90A {Homo sapiens} PDB: 3ecn_A* Length = 338 Back     alignment and structure
>3ecm_A High affinity CAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A...; phosphodiesterase 8A PDE8A inhibitor selectivity; 1.90A {Homo sapiens} PDB: 3ecn_A* Length = 338 Back     alignment and structure
>3hr1_A CAMP and CAMP-inhibited CGMP 3',5'-cyclic phosphodiesterase 10A; PDE 10A, PDE10 inhibitors, allosteric enzyme, alternative splicing; HET: PF9; 1.53A {Rattus norvegicus} PDB: 3hqy_A* 3hqz_A* 3hqw_A* Length = 380 Back     alignment and structure
>1y2k_A DPDE3, PDE43, CAMP-specific 3',5'-cyclic phosphodiesterase 4D; PDE4D, pyrazole, hydrolase; HET: 7DE; 1.36A {Homo sapiens} SCOP: a.211.1.2 PDB: 1xon_A* 1xoq_A* 1xom_A* 1xor_A* 1y2c_A* 1y2d_A* 1y2e_A* 1y2b_A* 3iak_A* 3k4s_A* 1tbb_A* 1tb7_A* 3sl5_A* 3sl4_A* 2fm5_A* 3sl3_A* 2fm0_A* 3sl6_A* 3sl8_A* 1oyn_A* ... Length = 349 Back     alignment and structure
>1y2k_A DPDE3, PDE43, CAMP-specific 3',5'-cyclic phosphodiesterase 4D; PDE4D, pyrazole, hydrolase; HET: 7DE; 1.36A {Homo sapiens} SCOP: a.211.1.2 PDB: 1xon_A* 1xoq_A* 1xom_A* 1xor_A* 1y2c_A* 1y2d_A* 1y2e_A* 1y2b_A* 3iak_A* 3k4s_A* 1tbb_A* 1tb7_A* 3sl5_A* 3sl4_A* 2fm5_A* 3sl3_A* 2fm0_A* 3sl6_A* 3sl8_A* 1oyn_A* ... Length = 349 Back     alignment and structure
>1f0j_A PDE4B, phosphodiesterase 4B; PDE phosphodiesterase, hydrolase; 1.77A {Homo sapiens} SCOP: a.211.1.2 PDB: 1ro6_A* 1ro9_A* 1ror_A* 3hmv_A* 1tb5_A* 1xm6_A* 1xlx_A* 1xm4_A* 1xlz_A* 1xmu_A* 1xmy_A* 1xn0_A* 1xos_A* 1xot_B* 1y2h_A* 1y2j_A* 3kkt_A* 3g4i_A* 3g4k_A* 3g4l_A* ... Length = 377 Back     alignment and structure
>1f0j_A PDE4B, phosphodiesterase 4B; PDE phosphodiesterase, hydrolase; 1.77A {Homo sapiens} SCOP: a.211.1.2 PDB: 1ro6_A* 1ro9_A* 1ror_A* 3hmv_A* 1tb5_A* 1xm6_A* 1xlx_A* 1xm4_A* 1xlz_A* 1xmu_A* 1xmy_A* 1xn0_A* 1xos_A* 1xot_B* 1y2h_A* 1y2j_A* 3kkt_A* 3g4i_A* 3g4k_A* 3g4l_A* ... Length = 377 Back     alignment and structure
>3g4g_A DPDE3, PDE43, CAMP-specific 3',5'-cyclic phosphodiesterase 4D; PDE4D, UCR2, alternative splicing, cytoplasm, cytoskeleton, hydrolase, membrane; HET: D71; 2.30A {Homo sapiens} PDB: 3g45_A* Length = 421 Back     alignment and structure
>3g4g_A DPDE3, PDE43, CAMP-specific 3',5'-cyclic phosphodiesterase 4D; PDE4D, UCR2, alternative splicing, cytoplasm, cytoskeleton, hydrolase, membrane; HET: D71; 2.30A {Homo sapiens} PDB: 3g45_A* Length = 421 Back     alignment and structure
>3qi3_A High affinity CGMP-specific 3',5'-cyclic phosphod 9A; mutation, glutamine switch, hydrolase-hydrolase inhibitor CO; HET: PDB; 2.30A {Homo sapiens} PDB: 3qi4_A* Length = 533 Back     alignment and structure
>3dyn_A High affinity CGMP-specific 3',5'-cyclic phosphod 9A; phophodiestrase, enzyme mechanism, hydrolase, manganes binding, phosphoprotein; HET: PCG IBM; 2.10A {Homo sapiens} SCOP: a.211.1.2 PDB: 3dyl_A* 3dy8_A* 3dyq_A* 3dys_A* 3jsi_A* 3jsw_A* 2yy2_A* 2hd1_A* 3k3e_A* 3k3h_A* 3n3z_A* Length = 329 Back     alignment and structure
>3bjc_A CGMP-specific 3',5'-cyclic phosphodiesterase; PDE5, erectIle dysfunction, inhibitor design, allosteric enzyme, alternative splicing, CGMP binding; HET: WAN; 2.00A {Homo sapiens} SCOP: a.211.1.2 PDB: 3mf0_A 3lfv_A 2xss_A 2k31_A* Length = 878 Back     alignment and structure
>3bjc_A CGMP-specific 3',5'-cyclic phosphodiesterase; PDE5, erectIle dysfunction, inhibitor design, allosteric enzyme, alternative splicing, CGMP binding; HET: WAN; 2.00A {Homo sapiens} SCOP: a.211.1.2 PDB: 3mf0_A 3lfv_A 2xss_A 2k31_A* Length = 878 Back     alignment and structure
>1so2_A CGMP-inhibited 3',5'-cyclic phosphodiesterase B; PDE3B phosphodiesterase, hydrolase; HET: HG9 666; 2.40A {Homo sapiens} SCOP: a.211.1.2 PDB: 1soj_A* Length = 420 Back     alignment and structure
>1so2_A CGMP-inhibited 3',5'-cyclic phosphodiesterase B; PDE3B phosphodiesterase, hydrolase; HET: HG9 666; 2.40A {Homo sapiens} SCOP: a.211.1.2 PDB: 1soj_A* Length = 420 Back     alignment and structure
>3ibj_A CGMP-dependent 3',5'-cyclic phosphodiesterase; PDE2A, GAF-domains, allosteric regulation hydrolase, membrane; 3.02A {Homo sapiens} Length = 691 Back     alignment and structure
>3ibj_A CGMP-dependent 3',5'-cyclic phosphodiesterase; PDE2A, GAF-domains, allosteric regulation hydrolase, membrane; 3.02A {Homo sapiens} Length = 691 Back     alignment and structure
>2r8q_A Class I phosphodiesterase PDEB1; leishimaniasis, parasite inhibitor selectivity, CAMP phosphodiesterase, hydrolase; HET: IBM; 1.50A {Leishmania major} Length = 359 Back     alignment and structure
>1taz_A Calcium/calmodulin-dependent 3',5'-cyclic nucleot phosphodiesterase 1B; PDE1B, hydrolase; HET: CME; 1.77A {Homo sapiens} SCOP: a.211.1.2 Length = 365 Back     alignment and structure
>1taz_A Calcium/calmodulin-dependent 3',5'-cyclic nucleot phosphodiesterase 1B; PDE1B, hydrolase; HET: CME; 1.77A {Homo sapiens} SCOP: a.211.1.2 Length = 365 Back     alignment and structure

Structure Templates Detected by HHsearch ?

Original result of HHsearch against PDB70 database

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query286
1tbf_A347 CGMP-specific 3',5'-cyclic phosphodiesterase; PDE5 100.0
2our_A331 CAMP and CAMP-inhibited CGMP 3',5'-cyclic phosphod 100.0
3itu_A345 CGMP-dependent 3',5'-cyclic phosphodiesterase; Zn- 100.0
3hr1_A380 CAMP and CAMP-inhibited CGMP 3',5'-cyclic phosphod 100.0
3dyn_A329 High affinity CGMP-specific 3',5'-cyclic phosphod 100.0
2r8q_A359 Class I phosphodiesterase PDEB1; leishimaniasis, p 100.0
3ibj_A691 CGMP-dependent 3',5'-cyclic phosphodiesterase; PDE 100.0
3qi3_A533 High affinity CGMP-specific 3',5'-cyclic phosphod 100.0
3bjc_A878 CGMP-specific 3',5'-cyclic phosphodiesterase; PDE5 100.0
1zkl_A353 HCP1, TM22, high-affinity CAMP-specific 3',5'-cycl 100.0
3v93_A345 Cyclic nucleotide specific phosphodiesterase; para 100.0
3ecm_A338 High affinity CAMP-specific and IBMX-insensitive 3 100.0
3g4g_A421 DPDE3, PDE43, CAMP-specific 3',5'-cyclic phosphodi 100.0
1y2k_A349 DPDE3, PDE43, CAMP-specific 3',5'-cyclic phosphodi 100.0
1f0j_A377 PDE4B, phosphodiesterase 4B; PDE phosphodiesterase 100.0
1taz_A365 Calcium/calmodulin-dependent 3',5'-cyclic nucleot 100.0
1so2_A420 CGMP-inhibited 3',5'-cyclic phosphodiesterase B; P 100.0
3hr1_A380 CAMP and CAMP-inhibited CGMP 3',5'-cyclic phosphod 97.5
3dyn_A329 High affinity CGMP-specific 3',5'-cyclic phosphod 97.47
3itu_A345 CGMP-dependent 3',5'-cyclic phosphodiesterase; Zn- 97.45
1tbf_A347 CGMP-specific 3',5'-cyclic phosphodiesterase; PDE5 97.39
2our_A331 CAMP and CAMP-inhibited CGMP 3',5'-cyclic phosphod 97.35
2r8q_A359 Class I phosphodiesterase PDEB1; leishimaniasis, p 97.33
3qi3_A533 High affinity CGMP-specific 3',5'-cyclic phosphod 97.22
3g4g_A421 DPDE3, PDE43, CAMP-specific 3',5'-cyclic phosphodi 97.19
1so2_A420 CGMP-inhibited 3',5'-cyclic phosphodiesterase B; P 97.11
3v93_A345 Cyclic nucleotide specific phosphodiesterase; para 96.98
3ecm_A338 High affinity CAMP-specific and IBMX-insensitive 3 96.98
1y2k_A349 DPDE3, PDE43, CAMP-specific 3',5'-cyclic phosphodi 96.96
1f0j_A377 PDE4B, phosphodiesterase 4B; PDE phosphodiesterase 96.94
3ibj_A691 CGMP-dependent 3',5'-cyclic phosphodiesterase; PDE 96.87
1taz_A365 Calcium/calmodulin-dependent 3',5'-cyclic nucleot 96.85
1zkl_A353 HCP1, TM22, high-affinity CAMP-specific 3',5'-cycl 96.83
3bjc_A878 CGMP-specific 3',5'-cyclic phosphodiesterase; PDE5 96.4
3irh_A 480 HD domain protein; phosphohydrolase, dntpase, stru 93.49
3u1n_A 528 SAM domain and HD domain-containing protein 1; deo 92.66
2q14_A 410 Phosphohydrolase; BT4208, HD domain, structural ge 91.36
3bg2_A 444 DGTP triphosphohydrolase; structural genomics, NYS 90.98
2pgs_A 451 Putative deoxyguanosinetriphosphate triphosphohyd; 89.84
2dqb_A 376 Deoxyguanosinetriphosphate triphosphohydrolase, P; 86.58
2hek_A 371 Hypothetical protein; predominantly alpha helical 81.04
>1tbf_A CGMP-specific 3',5'-cyclic phosphodiesterase; PDE5A, hydrolase; HET: VIA; 1.30A {Homo sapiens} SCOP: a.211.1.2 PDB: 1t9s_A* 1xoz_A* 1xp0_A* 2chm_A* 3tge_A* 3tgg_A* 3hc8_A* 3hdz_A* 1t9r_A* 3sie_A* 3shy_A* 3shz_A* 3b2r_A* 2h44_A* 2h42_A* 2h40_A* 1rkp_A* 1udt_A* 1udu_A* 1uho_A* ... Back     alignment and structure
Probab=100.00  E-value=2.5e-57  Score=429.20  Aligned_cols=228  Identities=32%  Similarity=0.559  Sum_probs=204.4

Q ss_pred             hhhhcCccChHHHhcCC---CCCCChhhhcCCCCCCCCCccCCchhhhhHHHHHHHHHhhcCchhhhcCC----------
Q psy14371          5 VIAYGSVYRDVKLHDLP---SLRVPSAAKLNLHDFKFDDIHMEDDDTLKVAELVSSEFFEQGDIERQELN----------   71 (286)
Q Consensus         5 ~~~y~~~~~~~e~~~l~---~~~~p~~~~~~l~~w~Fd~~~l~~~e~~~~~~~i~~~F~~~g~lekf~i~----------   71 (286)
                      -||||++|+++|++.|.   ...+|+....++++|+||+|++++.++.+++..   ||.+.|++++|+|+          
T Consensus        13 ~~~yh~~~~~~e~~~l~~~~~~~lp~~~~~~l~~w~Fd~~~l~~~~~~~~~~~---~f~~~~l~~~f~i~~~~L~~fl~~   89 (347)
T 1tbf_A           13 GLVPRGSHMEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIR---MFTDLNLVQNFQMKHEVLCRWILS   89 (347)
T ss_dssp             ---------CHHHHHHHHHHHSCCCCHHHHTTTCTTCCCTTCCHHHHHHHHHH---HHHHTTHHHHTTCCHHHHHHHHHH
T ss_pred             ccchhccCCHHHHHHHhhcccccCChhhhcCCCCCCCCcccCCchhHHHHHHH---HHHHCChHhhcCCCHHHHHHHHHH
Confidence            37999999999999998   478999888899999999999999998877765   99999999999874          


Q ss_pred             ----CC-CCCCCCccccCCccccccccccccccccccccchhhhhchHHHHHHHHHHHhccCCCCCCCCccccc------
Q psy14371         72 ----IT-PIDIMNREKEDQLPLMQVGFIDSICLPIYESTQWWKIFGEIECLALLIACLCHDLDHRGTNNSFQIN------  140 (286)
Q Consensus        72 ----Y~-~~pyHN~~~~Ha~~v~Q~~f~~~~~~~l~~~~~l~~~l~~~e~lalliaal~HDvdH~G~nN~f~~~------  140 (286)
                          |+ +|||||+.  ||++|+|      +++.++..+++...++++|++|+++||+|||+||||+||.|+++      
T Consensus        90 v~~~Y~~~npYHN~~--HA~dV~q------~~~~ll~~~~l~~~l~~le~~alliAAl~HDv~HpG~~N~fli~~~s~LA  161 (347)
T 1tbf_A           90 VKKNYRKNVAYHNWR--HAFNTAQ------CMFAALKAGKIQNKLTDLEILALLIAALSHDLDHPGVSNQFLINTNSELA  161 (347)
T ss_dssp             HHHTSCTTSSSSSHH--HHHHHHH------HHHHHHHTTCCGGGSCHHHHHHHHHHHHHTTTTCCSSCHHHHHHTTCHHH
T ss_pred             HHHhcCCCCCCcCHH--HHHHHHH------HHHHHHHcccccccCCHHHHHHHHHHHHHccCCCCCCCCchHHhcCCHHH
Confidence                99 79999999  9999999      99999998888899999999999999999999999999999988      


Q ss_pred             ------------------------------CCCHHHHHHHHHHHHHHHHhcchhhHHHHHHHHHHHHhCCCcccccccch
Q psy14371        141 ------------------------------NVSPDEYSRIIKVLEEAILSTDLAVYFRQRGSFLSLVKGGSLAWHREADR  190 (286)
Q Consensus       141 ------------------------------~L~~~~~~~~r~~ii~~ILATDMa~Hf~~~~~f~~~~~~~~~~~~~~~~~  190 (286)
                                                    +|++++++.+|++||++||||||++||+++++|++++..+          
T Consensus       162 ~lYnd~SvLEnhH~a~a~~iL~~~~~ni~~~l~~~~~~~~r~~ii~~ILATDM~~Hf~~~~~~~~~~~~~----------  231 (347)
T 1tbf_A          162 LMYNDESVLEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKN----------  231 (347)
T ss_dssp             HHTTTSSHHHHHHHHHHHHHHHSTTCCTTTTSCHHHHHHHHHHHHHHHHHTSHHHHHHHHHHHHHHHHTT----------
T ss_pred             HHcCCCcHHHHHHHHHHHHHHcCcccchhhcCCHHHHHHHHHHHHHHHHHccHHHHHHHHHHHHHHHhcC----------
Confidence                                          6789999999999999999999999999999999988754          


Q ss_pred             hhhHhhhccccccccccCCCCCCCChhhHHHHHHHhhhhccCcCCCCChHHHHH--------------------------
Q psy14371        191 DLAVYFRQRGSFLSLVKGGSLAWHREADRGLLRGMTMTVCDLAAITKPWHVEKR--------------------------  244 (286)
Q Consensus       191 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~r~ll~~~ii~~aDisn~~kp~~v~~k--------------------------  244 (286)
                                         .+++.++++|.++++++||||||||++|||+++++                          
T Consensus       232 -------------------~~~~~~~~~r~ll~~~iik~ADis~~~rp~~~~~~W~~~l~eEF~~Qgd~Ek~~Lgl~~sp  292 (347)
T 1tbf_A          232 -------------------QFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTD  292 (347)
T ss_dssp             -------------------CCCTTSHHHHHHHHHHHHHHHHTGGGGSCHHHHHHHHHHHHHHHHHHHHHHHHHTCCCCCG
T ss_pred             -------------------CCCCCChHHHHHHHHHHHHHhccccccCCHHHHHHHHHHHHHHHHHHHHHHHHhcCCCCCc
Confidence                               57788999999999999999999999999999988                          


Q ss_pred             ---------------------------HHHHHccChHHHHHHHHHHHHHHHHHHH
Q psy14371        245 ---------------------------AFAELSDKLEPLVEGVRSNKQHWLEIAA  272 (286)
Q Consensus       245 ---------------------------~~a~~~p~~~~~~~~~~~N~~~W~~~~~  272 (286)
                                                 ++++++|+++++++++++|+++|+++++
T Consensus       293 ~~DR~~~~~~~k~QigFi~~iv~Pl~~~l~~~~p~~~~~~~~~~~N~~~W~~l~~  347 (347)
T 1tbf_A          293 LMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAE  347 (347)
T ss_dssp             GGCGGGGGGHHHHHHHHHHHTHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHHHHC
T ss_pred             ccCcccccccHHHHHHHHHHHHHHHHHHHHHHChhhHHHHHHHHHHHHHHHHhhC
Confidence                                       5788999999999999999999998763
>2our_A CAMP and CAMP-inhibited CGMP 3',5'-cyclic phosphodiesterase 10A; PDE10, substrate specificity, hydrolase; HET: CMP; 1.45A {Homo sapiens} PDB: 2ous_A 2ouu_A* 3sn7_A* 3sni_A* 3snl_A* 4dff_A* 2wey_A* 2oun_A* 2oup_A 2ouq_A* 2ouv_A 2ouy_A* 4ael_A* 2y0j_A* 4ddl_A* 3uuo_A* 3ui7_A* 2o8h_A* 2ovv_A* 2ovy_A* ... Back     alignment and structure
>3itu_A CGMP-dependent 3',5'-cyclic phosphodiesterase; Zn-binding, all-alpha-helical, alternative splicing, hydrolase, membrane, polymorphism; HET: IBM; 1.58A {Homo sapiens} PDB: 3itm_A* 1z1l_A Back     alignment and structure
>3hr1_A CAMP and CAMP-inhibited CGMP 3',5'-cyclic phosphodiesterase 10A; PDE 10A, PDE10 inhibitors, allosteric enzyme, alternative splicing; HET: PF9; 1.53A {Rattus norvegicus} PDB: 3hqy_A* 3hqz_A* 3hqw_A* Back     alignment and structure
>3dyn_A High affinity CGMP-specific 3',5'-cyclic phosphod 9A; phophodiestrase, enzyme mechanism, hydrolase, manganes binding, phosphoprotein; HET: PCG IBM; 2.10A {Homo sapiens} SCOP: a.211.1.2 PDB: 3dyl_A* 3dy8_A* 3dyq_A* 3dys_A* 3jsi_A* 3jsw_A* 2yy2_A* 2hd1_A* 3k3e_A* 3k3h_A* 4gh6_A* 3n3z_A* Back     alignment and structure
>2r8q_A Class I phosphodiesterase PDEB1; leishimaniasis, parasite inhibitor selectivity, CAMP phosphodiesterase, hydrolase; HET: IBM; 1.50A {Leishmania major} Back     alignment and structure
>3ibj_A CGMP-dependent 3',5'-cyclic phosphodiesterase; PDE2A, GAF-domains, allosteric regulation hydrolase, membrane; 3.02A {Homo sapiens} Back     alignment and structure
>3qi3_A High affinity CGMP-specific 3',5'-cyclic phosphod 9A; mutation, glutamine switch, hydrolase-hydrolase inhibitor CO; HET: PDB; 2.30A {Homo sapiens} PDB: 3qi4_A* Back     alignment and structure
>3bjc_A CGMP-specific 3',5'-cyclic phosphodiesterase; PDE5, erectIle dysfunction, inhibitor design, allosteric enzyme, alternative splicing, CGMP binding; HET: WAN; 2.00A {Homo sapiens} SCOP: a.211.1.2 PDB: 3mf0_A 3lfv_A 2xss_A 2k31_A* Back     alignment and structure
>1zkl_A HCP1, TM22, high-affinity CAMP-specific 3',5'-cyclic phosphodiesterase 7A; PDE, hydrolase; HET: IBM; 1.67A {Homo sapiens} PDB: 3g3n_A* Back     alignment and structure
>3v93_A Cyclic nucleotide specific phosphodiesterase; parasite, phosphodiesterases,, hydrolase; 2.00A {Trypanosoma cruzi} PDB: 3v94_A* Back     alignment and structure
>3ecm_A High affinity CAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A...; phosphodiesterase 8A PDE8A inhibitor selectivity; 1.90A {Homo sapiens} SCOP: a.211.1.0 PDB: 3ecn_A* Back     alignment and structure
>3g4g_A DPDE3, PDE43, CAMP-specific 3',5'-cyclic phosphodiesterase 4D; PDE4D, UCR2, alternative splicing, cytoplasm, cytoskeleton, hydrolase, membrane; HET: D71; 2.30A {Homo sapiens} PDB: 3g45_A* Back     alignment and structure
>1y2k_A DPDE3, PDE43, CAMP-specific 3',5'-cyclic phosphodiesterase 4D; PDE4D, pyrazole, hydrolase; HET: 7DE; 1.36A {Homo sapiens} SCOP: a.211.1.2 PDB: 1xon_A* 1xoq_A* 1xom_A* 1xor_A* 1y2c_A* 1y2d_A* 1y2e_A* 1y2b_A* 3iak_A* 3k4s_A* 1tbb_A* 1tb7_A* 3sl5_A* 3sl4_A* 2fm5_A* 3sl3_A* 2fm0_A* 3sl6_A* 3sl8_A* 1oyn_A* ... Back     alignment and structure
>1f0j_A PDE4B, phosphodiesterase 4B; PDE phosphodiesterase, hydrolase; 1.77A {Homo sapiens} SCOP: a.211.1.2 PDB: 1ro6_A* 1ro9_A* 1ror_A* 3hmv_A* 1tb5_A* 1xm6_A* 1xlx_A* 1xm4_A* 1xlz_A* 1xmu_A* 1xmy_A* 1xn0_A* 1xos_A* 1xot_B* 1y2h_A* 1y2j_A* 3kkt_A* 3g4i_A* 3g4k_A* 3g4l_A* ... Back     alignment and structure
>1taz_A Calcium/calmodulin-dependent 3',5'-cyclic nucleot phosphodiesterase 1B; PDE1B, hydrolase; HET: CME; 1.77A {Homo sapiens} SCOP: a.211.1.2 Back     alignment and structure
>1so2_A CGMP-inhibited 3',5'-cyclic phosphodiesterase B; PDE3B phosphodiesterase, hydrolase; HET: HG9 666; 2.40A {Homo sapiens} SCOP: a.211.1.2 PDB: 1soj_A* Back     alignment and structure
>3hr1_A CAMP and CAMP-inhibited CGMP 3',5'-cyclic phosphodiesterase 10A; PDE 10A, PDE10 inhibitors, allosteric enzyme, alternative splicing; HET: PF9; 1.53A {Rattus norvegicus} PDB: 3hqy_A* 3hqz_A* 3hqw_A* Back     alignment and structure
>3dyn_A High affinity CGMP-specific 3',5'-cyclic phosphod 9A; phophodiestrase, enzyme mechanism, hydrolase, manganes binding, phosphoprotein; HET: PCG IBM; 2.10A {Homo sapiens} SCOP: a.211.1.2 PDB: 3dyl_A* 3dy8_A* 3dyq_A* 3dys_A* 3jsi_A* 3jsw_A* 2yy2_A* 2hd1_A* 3k3e_A* 3k3h_A* 4gh6_A* 3n3z_A* Back     alignment and structure
>3itu_A CGMP-dependent 3',5'-cyclic phosphodiesterase; Zn-binding, all-alpha-helical, alternative splicing, hydrolase, membrane, polymorphism; HET: IBM; 1.58A {Homo sapiens} PDB: 3itm_A* 1z1l_A Back     alignment and structure
>1tbf_A CGMP-specific 3',5'-cyclic phosphodiesterase; PDE5A, hydrolase; HET: VIA; 1.30A {Homo sapiens} SCOP: a.211.1.2 PDB: 1t9s_A* 1xoz_A* 1xp0_A* 2chm_A* 3tge_A* 3tgg_A* 3hc8_A* 3hdz_A* 1t9r_A* 3sie_A* 3shy_A* 3shz_A* 3b2r_A* 2h44_A* 2h42_A* 2h40_A* 1rkp_A* 1udt_A* 1udu_A* 1uho_A* ... Back     alignment and structure
>2our_A CAMP and CAMP-inhibited CGMP 3',5'-cyclic phosphodiesterase 10A; PDE10, substrate specificity, hydrolase; HET: CMP; 1.45A {Homo sapiens} PDB: 2ous_A 2ouu_A* 3sn7_A* 3sni_A* 3snl_A* 4dff_A* 2wey_A* 2oun_A* 2oup_A 2ouq_A* 2ouv_A 2ouy_A* 4ael_A* 2y0j_A* 4ddl_A* 3uuo_A* 3ui7_A* 2o8h_A* 2ovv_A* 2ovy_A* ... Back     alignment and structure
>2r8q_A Class I phosphodiesterase PDEB1; leishimaniasis, parasite inhibitor selectivity, CAMP phosphodiesterase, hydrolase; HET: IBM; 1.50A {Leishmania major} Back     alignment and structure
>3qi3_A High affinity CGMP-specific 3',5'-cyclic phosphod 9A; mutation, glutamine switch, hydrolase-hydrolase inhibitor CO; HET: PDB; 2.30A {Homo sapiens} PDB: 3qi4_A* Back     alignment and structure
>3g4g_A DPDE3, PDE43, CAMP-specific 3',5'-cyclic phosphodiesterase 4D; PDE4D, UCR2, alternative splicing, cytoplasm, cytoskeleton, hydrolase, membrane; HET: D71; 2.30A {Homo sapiens} PDB: 3g45_A* Back     alignment and structure
>1so2_A CGMP-inhibited 3',5'-cyclic phosphodiesterase B; PDE3B phosphodiesterase, hydrolase; HET: HG9 666; 2.40A {Homo sapiens} SCOP: a.211.1.2 PDB: 1soj_A* Back     alignment and structure
>3v93_A Cyclic nucleotide specific phosphodiesterase; parasite, phosphodiesterases,, hydrolase; 2.00A {Trypanosoma cruzi} PDB: 3v94_A* Back     alignment and structure
>3ecm_A High affinity CAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A...; phosphodiesterase 8A PDE8A inhibitor selectivity; 1.90A {Homo sapiens} SCOP: a.211.1.0 PDB: 3ecn_A* Back     alignment and structure
>1y2k_A DPDE3, PDE43, CAMP-specific 3',5'-cyclic phosphodiesterase 4D; PDE4D, pyrazole, hydrolase; HET: 7DE; 1.36A {Homo sapiens} SCOP: a.211.1.2 PDB: 1xon_A* 1xoq_A* 1xom_A* 1xor_A* 1y2c_A* 1y2d_A* 1y2e_A* 1y2b_A* 3iak_A* 3k4s_A* 1tbb_A* 1tb7_A* 3sl5_A* 3sl4_A* 2fm5_A* 3sl3_A* 2fm0_A* 3sl6_A* 3sl8_A* 1oyn_A* ... Back     alignment and structure
>1f0j_A PDE4B, phosphodiesterase 4B; PDE phosphodiesterase, hydrolase; 1.77A {Homo sapiens} SCOP: a.211.1.2 PDB: 1ro6_A* 1ro9_A* 1ror_A* 3hmv_A* 1tb5_A* 1xm6_A* 1xlx_A* 1xm4_A* 1xlz_A* 1xmu_A* 1xmy_A* 1xn0_A* 1xos_A* 1xot_B* 1y2h_A* 1y2j_A* 3kkt_A* 3g4i_A* 3g4k_A* 3g4l_A* ... Back     alignment and structure
>3ibj_A CGMP-dependent 3',5'-cyclic phosphodiesterase; PDE2A, GAF-domains, allosteric regulation hydrolase, membrane; 3.02A {Homo sapiens} Back     alignment and structure
>1taz_A Calcium/calmodulin-dependent 3',5'-cyclic nucleot phosphodiesterase 1B; PDE1B, hydrolase; HET: CME; 1.77A {Homo sapiens} SCOP: a.211.1.2 Back     alignment and structure
>1zkl_A HCP1, TM22, high-affinity CAMP-specific 3',5'-cyclic phosphodiesterase 7A; PDE, hydrolase; HET: IBM; 1.67A {Homo sapiens} PDB: 3g3n_A* Back     alignment and structure
>3bjc_A CGMP-specific 3',5'-cyclic phosphodiesterase; PDE5, erectIle dysfunction, inhibitor design, allosteric enzyme, alternative splicing, CGMP binding; HET: WAN; 2.00A {Homo sapiens} SCOP: a.211.1.2 PDB: 3mf0_A 3lfv_A 2xss_A 2k31_A* Back     alignment and structure
>3irh_A HD domain protein; phosphohydrolase, dntpase, structural genomics, P protein structure initiative, midwest center for structural genomics; HET: DGT DTP; 2.40A {Enterococcus faecalis} PDB: 2o6i_A* Back     alignment and structure
>3u1n_A SAM domain and HD domain-containing protein 1; deoxynucleotide triphosphohydrolase, hydrolase; 3.10A {Homo sapiens} Back     alignment and structure
>2q14_A Phosphohydrolase; BT4208, HD domain, structural genomics, JO center for structural genomics, JCSG; HET: MSE ADP; 2.20A {Bacteroides thetaiotaomicron vpi-5482} Back     alignment and structure
>3bg2_A DGTP triphosphohydrolase; structural genomics, NYSGXRC, target 10395N, triphosphohydro PSI-2, protein structure initiative; 1.95A {Leeuwenhoekiella blandensis} Back     alignment and structure
>2pgs_A Putative deoxyguanosinetriphosphate triphosphohyd; deoxyguanosinetriphosphate triphsphohydrolase, pseudomonas S PV. phaseolicola 1448A; 2.35A {Pseudomonas syringae PV} Back     alignment and structure
>2dqb_A Deoxyguanosinetriphosphate triphosphohydrolase, P; dntpase, DNTP, single-stranded DNA, DNA dGTPase, HD superfamily, structural genomics; 2.20A {Thermus thermophilus} Back     alignment and structure
>2hek_A Hypothetical protein; predominantly alpha helical protein with GDP binding site AN site being FAR from EACH other, structural genomics, PSI; HET: GDP; 2.00A {Aquifex aeolicus} SCOP: a.211.1.1 Back     alignment and structure

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST ?

Original result of RPS-BLAST against SCOP70(version1.75) database

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query 286
d1tbfa_326 a.211.1.2 (A:) cGMP-specific 3',5'-cyclic phosphod 4e-22
d3dy8a1324 a.211.1.2 (A:182-505) High-affinity cGMP-specific 2e-16
d1so2a_415 a.211.1.2 (A:) cGMP-inhibited 3',5'-cyclic phospho 3e-16
d1so2a_415 a.211.1.2 (A:) cGMP-inhibited 3',5'-cyclic phospho 4e-10
d1taza_357 a.211.1.2 (A:) Catalytic domain of cyclic nucleoti 8e-14
d1taza_357 a.211.1.2 (A:) Catalytic domain of cyclic nucleoti 4e-09
d1y2ka1326 a.211.1.2 (A:86-411) Catalytic domain of cyclic nu 9e-14
d1y2ka1326 a.211.1.2 (A:86-411) Catalytic domain of cyclic nu 1e-07
>d1tbfa_ a.211.1.2 (A:) cGMP-specific 3',5'-cyclic phosphodiesterase pde5a1-Ibmx {Human (Homo sapiens) [TaxId: 9606]} Length = 326 Back     information, alignment and structure

class: All alpha proteins
fold: HD-domain/PDEase-like
superfamily: HD-domain/PDEase-like
family: PDEase
domain: cGMP-specific 3',5'-cyclic phosphodiesterase pde5a1-Ibmx
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.6 bits (227), Expect = 4e-22
 Identities = 76/347 (21%), Positives = 118/347 (34%), Gaps = 118/347 (34%)

Query: 16  KLHDLPSLRVPSAAKLNLHDFKFDDIHMEDDDTLKVAELVSSEFFEQGDIERQELNITPI 75
           +L  L +  VPSA  L + DF F D  + D +T      +   F +   ++     +   
Sbjct: 6   ELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRM---FTDLNLVQN--FQMKHE 60

Query: 76  DIMNREKEDQLPLMQVGFIDSI----------------------CLPIYESTQWWKIFGE 113
            +               +I S+                           ++ +      +
Sbjct: 61  VLCR-------------WILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQNKLTD 107

Query: 114 IECLALLIACLCHDLDHRGTNNSFQINNVSP----------------DEYSRIIKVLEEA 157
           +E LALLIA L HDLDH G +N F IN  S                 D+   I+      
Sbjct: 108 LEILALLIAALSHDLDHPGVSNQFLINTNSELALMYNDESVLEHHHFDQCLMILNSPGNQ 167

Query: 158 ILSTDLAVYFRQRGSFLSLVKGGSLAWHREADRDLAVYFRQRGSFLSLVKGGSLAWHREA 217
           ILS    +   +  + L ++K   LA       DLA+Y ++RG F  L++          
Sbjct: 168 ILSG---LSIEEYKTTLKIIKQAILA------TDLALYIKRRGEFFELIRKNQFNLEDPH 218

Query: 218 DRGLLRGMTMTVCDLAAITKPWHVEKR--------------------------------- 244
            + L   M MT CDL+AITKPW +++R                                 
Sbjct: 219 QKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKK 278

Query: 245 --------------------AFAELSDKLEPLVEGVRSNKQHWLEIA 271
                               A   +S+   PL++G R N+Q W  +A
Sbjct: 279 NKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALA 325
>d3dy8a1 a.211.1.2 (A:182-505) High-affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A, PDE9A {Human (Homo sapiens) [TaxId: 9606]} Length = 324 Back     information, alignment and structure
>d1so2a_ a.211.1.2 (A:) cGMP-inhibited 3',5'-cyclic phosphodiesterase B, pde3b {Human (Homo sapiens) [TaxId: 9606]} Length = 415 Back     information, alignment and structure
>d1so2a_ a.211.1.2 (A:) cGMP-inhibited 3',5'-cyclic phosphodiesterase B, pde3b {Human (Homo sapiens) [TaxId: 9606]} Length = 415 Back     information, alignment and structure
>d1taza_ a.211.1.2 (A:) Catalytic domain of cyclic nucleotide phosphodiesterase 1b, PDE1B {Human (Homo sapiens) [TaxId: 9606]} Length = 357 Back     information, alignment and structure
>d1taza_ a.211.1.2 (A:) Catalytic domain of cyclic nucleotide phosphodiesterase 1b, PDE1B {Human (Homo sapiens) [TaxId: 9606]} Length = 357 Back     information, alignment and structure
>d1y2ka1 a.211.1.2 (A:86-411) Catalytic domain of cyclic nucleotide phosphodiesterase pde4d {Human (Homo sapiens) [TaxId: 9606]} Length = 326 Back     information, alignment and structure
>d1y2ka1 a.211.1.2 (A:86-411) Catalytic domain of cyclic nucleotide phosphodiesterase pde4d {Human (Homo sapiens) [TaxId: 9606]} Length = 326 Back     information, alignment and structure

Homologous Domains Detected by HHsearch ?

Original result of HHsearch against SCOP70(version1.75) database

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query286
d1tbfa_326 cGMP-specific 3',5'-cyclic phosphodiesterase pde5a 100.0
d3dy8a1324 High-affinity cGMP-specific 3',5'-cyclic phosphodi 100.0
d1y2ka1326 Catalytic domain of cyclic nucleotide phosphodiest 100.0
d1so2a_415 cGMP-inhibited 3',5'-cyclic phosphodiesterase B, p 100.0
d1taza_357 Catalytic domain of cyclic nucleotide phosphodiest 100.0
d1tbfa_326 cGMP-specific 3',5'-cyclic phosphodiesterase pde5a 96.59
d3dy8a1324 High-affinity cGMP-specific 3',5'-cyclic phosphodi 96.52
d1so2a_415 cGMP-inhibited 3',5'-cyclic phosphodiesterase B, p 96.49
d1taza_357 Catalytic domain of cyclic nucleotide phosphodiest 96.28
d1y2ka1326 Catalytic domain of cyclic nucleotide phosphodiest 95.47
d2heka1 369 Hypothetical protein aq_1910 {Aquifex aeolicus [Ta 94.89
d2o6ia1 453 Hypothetical protein EF1143 {Enterococcus faecalis 93.64
d3dtoa1212 Uncharacterized protein BH2835 {Bacillus haloduran 87.67
>d1tbfa_ a.211.1.2 (A:) cGMP-specific 3',5'-cyclic phosphodiesterase pde5a1-Ibmx {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
class: All alpha proteins
fold: HD-domain/PDEase-like
superfamily: HD-domain/PDEase-like
family: PDEase
domain: cGMP-specific 3',5'-cyclic phosphodiesterase pde5a1-Ibmx
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-53  Score=393.77  Aligned_cols=218  Identities=34%  Similarity=0.600  Sum_probs=202.6

Q ss_pred             HHHhcCCCCCCChhhhcCCCCCCCCCccCCchhhhhHHHHHHHHHhhcCchhhhcCC--------------CC-CCCCCC
Q psy14371         15 VKLHDLPSLRVPSAAKLNLHDFKFDDIHMEDDDTLKVAELVSSEFFEQGDIERQELN--------------IT-PIDIMN   79 (286)
Q Consensus        15 ~e~~~l~~~~~p~~~~~~l~~w~Fd~~~l~~~e~~~~~~~i~~~F~~~g~lekf~i~--------------Y~-~~pyHN   79 (286)
                      .|++.+....+|.....++.+|+|++|.++++++++++..   +|.+.|++++|+|+              |+ +|||||
T Consensus         5 ~~~~~~~~~~~p~~~~~~~~~~~F~~~~~~~~el~~~~~~---~F~~~~l~~~~~i~~~~l~~Fl~~v~~~Y~~~~pyHN   81 (326)
T d1tbfa_           5 RELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIR---MFTDLNLVQNFQMKHEVLCRWILSVKKNYRKNVAYHN   81 (326)
T ss_dssp             HHHHHHHHSCCCCHHHHTTTCTTCCCTTCCHHHHHHHHHH---HHHHTTHHHHTTCCHHHHHHHHHHHHHTSCTTSSSSS
T ss_pred             HHHHhhhhccCCcHHHcCcCCCCcCCCcCChHHHHHHHHH---HHHHCCchhhcCCCHHHHHHHHHHHHHhCCCCCCCcc
Confidence            4566667788999888899999999999999999888776   99999999999874              87 589999


Q ss_pred             ccccCCccccccccccccccccccccchhhhhchHHHHHHHHHHHhccCCCCCCCCccccc-------------------
Q psy14371         80 REKEDQLPLMQVGFIDSICLPIYESTQWWKIFGEIECLALLIACLCHDLDHRGTNNSFQIN-------------------  140 (286)
Q Consensus        80 ~~~~Ha~~v~Q~~f~~~~~~~l~~~~~l~~~l~~~e~lalliaal~HDvdH~G~nN~f~~~-------------------  140 (286)
                      |.  ||+||+|      +++.++..+++...++++|++|+++||+|||+||||+||.|+++                   
T Consensus        82 ~~--HA~dV~q------~~~~~l~~~~l~~~l~~~e~~alliAal~HDv~HpG~~N~flv~~~s~la~~ynd~SvLE~~H  153 (326)
T d1tbfa_          82 WR--HAFNTAQ------CMFAALKAGKIQNKLTDLEILALLIAALSHDLDHPGVSNQFLINTNSELALMYNDESVLEHHH  153 (326)
T ss_dssp             HH--HHHHHHH------HHHHHHHTTCCGGGSCHHHHHHHHHHHHHTTTTCCSSCHHHHHHTTCHHHHHTTTSSHHHHHH
T ss_pred             HH--HHHHHHH------HHHHHHhcCCCCccCCHHHHHHHHHHHHHhccCCCCcchHHHHhcCCHHHHHhCCccHHHHHH
Confidence            99  9999999      99999999889999999999999999999999999999999998                   


Q ss_pred             -----------------CCCHHHHHHHHHHHHHHHHhcchhhHHHHHHHHHHHHhCCCcccccccchhhhHhhhcccccc
Q psy14371        141 -----------------NVSPDEYSRIIKVLEEAILSTDLAVYFRQRGSFLSLVKGGSLAWHREADRDLAVYFRQRGSFL  203 (286)
Q Consensus       141 -----------------~L~~~~~~~~r~~ii~~ILATDMa~Hf~~~~~f~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  203 (286)
                                       +++.++++.+|++|+++||||||++||+++++|++.+..+                       
T Consensus       154 ~~~~~~iL~~~~~ni~~~l~~~~~~~~~~~ii~~ILaTDm~~H~~~~~~~~~~~~~~-----------------------  210 (326)
T d1tbfa_         154 FDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIRKN-----------------------  210 (326)
T ss_dssp             HHHHHHHHHSTTCCTTTTSCHHHHHHHHHHHHHHHHHTSHHHHHHHHHHHHHHHHTT-----------------------
T ss_pred             HHHHHHHHHhcchhhhhcCCHHHHHHHHHHHHHHHHhccHHHHHHHHHHHHHHHhcC-----------------------
Confidence                             6889999999999999999999999999999999988754                       


Q ss_pred             ccccCCCCCCCChhhHHHHHHHhhhhccCcCCCCChHHHHH---------------------------------------
Q psy14371        204 SLVKGGSLAWHREADRGLLRGMTMTVCDLAAITKPWHVEKR---------------------------------------  244 (286)
Q Consensus       204 ~~~~~~~~~~~~~~~r~ll~~~ii~~aDisn~~kp~~v~~k---------------------------------------  244 (286)
                            .+++.++++|.++++++||||||||++|||+++++                                       
T Consensus       211 ------~~~~~~~~~r~lll~~llk~ADis~~~rp~~~~~~W~~~l~~Ef~~Qgd~e~~~~~~~~~~~~dr~~~~~~~~~  284 (326)
T d1tbfa_         211 ------QFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPTDLMNREKKNKIPSM  284 (326)
T ss_dssp             ------CCCTTSHHHHHHHHHHHHHHHHTGGGGSCHHHHHHHHHHHHHHHHHHHHHHHHHTCCCCCGGGCGGGGGGHHHH
T ss_pred             ------CCCCCCHHHHHHHHHHHHHHhhcccccCChHHHHHHHHHHHHHHHHhhhHHHHhcCCCCCCccCcccccccHHH
Confidence                  57788999999999999999999999999999999                                       


Q ss_pred             --------------HHHHHccChHHHHHHHHHHHHHHHHHHH
Q psy14371        245 --------------AFAELSDKLEPLVEGVRSNKQHWLEIAA  272 (286)
Q Consensus       245 --------------~~a~~~p~~~~~~~~~~~N~~~W~~~~~  272 (286)
                                    ++++++|+++++++++++|+++|++++|
T Consensus       285 Qi~Fi~~iv~Pl~~~l~~~~p~l~~~~~~~~~N~~~W~~l~e  326 (326)
T d1tbfa_         285 QVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAE  326 (326)
T ss_dssp             HHHHHHHTHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHHChhHHHHHHHHHHHHHHHHHhhC
Confidence                          6789999999999999999999999864
>d3dy8a1 a.211.1.2 (A:182-505) High-affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A, PDE9A {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1y2ka1 a.211.1.2 (A:86-411) Catalytic domain of cyclic nucleotide phosphodiesterase pde4d {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1so2a_ a.211.1.2 (A:) cGMP-inhibited 3',5'-cyclic phosphodiesterase B, pde3b {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1taza_ a.211.1.2 (A:) Catalytic domain of cyclic nucleotide phosphodiesterase 1b, PDE1B {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1tbfa_ a.211.1.2 (A:) cGMP-specific 3',5'-cyclic phosphodiesterase pde5a1-Ibmx {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d3dy8a1 a.211.1.2 (A:182-505) High-affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A, PDE9A {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1so2a_ a.211.1.2 (A:) cGMP-inhibited 3',5'-cyclic phosphodiesterase B, pde3b {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1taza_ a.211.1.2 (A:) Catalytic domain of cyclic nucleotide phosphodiesterase 1b, PDE1B {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1y2ka1 a.211.1.2 (A:86-411) Catalytic domain of cyclic nucleotide phosphodiesterase pde4d {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2heka1 a.211.1.1 (A:1-369) Hypothetical protein aq_1910 {Aquifex aeolicus [TaxId: 63363]} Back     information, alignment and structure
>d2o6ia1 a.211.1.1 (A:1-453) Hypothetical protein EF1143 {Enterococcus faecalis [TaxId: 1351]} Back     information, alignment and structure
>d3dtoa1 a.211.1.1 (A:2-213) Uncharacterized protein BH2835 {Bacillus halodurans [TaxId: 86665]} Back     information, alignment and structure